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Tumor Suppressor Candidate 2 (TUSC2) is a novel tumor suppressor gene located in
the human chromosome 3p21.3 region. TUSC2 mRNA transcripts could be detected on
Northern blots in both normal lung and some lung cancer cell lines, but no endogenous
TUSC2 protein could be detected in a majority of lung cancer cell lines. Mechanisms
regulating TUSC2 protein expression and its inactivation in primary lung cancer cells are
largely unknown. We investigated the role of the 5’- and 3’-untranslated regions (UTRs)
of the TUSC2 gene in the regulation of TUSC2 protein expression. We found that two
small upstream open-reading frames (uORFs) in the 5’UTR of TUSC2 could markedly
inhibit the translational initiation of TUSC2 protein by interfering with the “scanning” of
the ribosome initiation complexes. Site-specific stem-loop array reverse transcriptionpolymerase chain reaction (SLA-RT-PCR) verified several micoRNAs (miRNAs)
targeted at 3’UTR and directed TUSC2 cleavage and degradation.
In addition, we used the established let-7-targeted high mobility group A2 (Hmga2)
mRNA as a model system to study the mechanism of regulation of target mRNA by
miRNAs in mammalian cells under physiological conditions. There have been no
evidence of direct link between mRNA downregulation and mRNA cleavages mediated
by miRNAs. Here we showed that the endonucleolytic cleavages on mRNAs were
vi

initiated by mammalian miRNA in seed pairing style. Let-7 directed cleavage activities
among the eight predicted potential target sites have varied efficiency, which are
influenced by the positional and the structural contexts in the UTR. The 5’ cleaved RNA
fragments were mostly oligouridylated at their 3’-termini and accumulated for delayed
5’–3’ degradation. RNA fragment oligouridylation played important roles in marking
RNA fragments for delayed bulk degradation and in converting RNA degradation mode
from 3’–5’ to 5’–3’ with cooperative efforts from both endonucleolytic and non-catalytic
miRNA-induced silencing complex (miRISC). Our findings point to a mammalian
miRNA-mediated mechanism for the regulation of mRNA that miRNA can decrease
target mRNA through target mRNA cleavage and uridine addition.
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Chapter 1. Overview
RNAs are divided into two classes: messenger RNAs (mRNAs), which are translated
into proteins, and non-coding RNAs (ncRNAs), which does not encode protein.
However, this does not mean that such ncRNAs do not contain information nor have
function. Although it has been traditionally thought that most important genetic
information is translated to proteins, recent evidence suggests that the majority of the
genomes is transcribed into ncRNAs. The total fraction of protein-coding transcripts is
about 1.4% in humans, whereas about 27% is transcribed as introns and UTRs
(untranslated regions) but not translated [1, 2], which further increase the space for
potential novel ncRNAs.
Most genomic DNA can be regulated at either the transcriptional level, controlling
whether a gene is transcribed or not, or at the post-transcriptional level, controlling the
fate of the transcribed RNA molecules, including their stability, the efficiency of their
translation and their subcellular localization. The past few years have seen a rapid
expansion in the identification and characterization of mRNA regulatory elements in
UTRs.
1.1 Post-transcriptional regulation of gene expression in UTRs of mRNA
UTRs play crucial roles in the post-transcriptional regulation of gene expression,
which control mRNA stability [3], translation efficiency [4], and subcellular localization
[5]. The turnover of mRNAs is a crucial step in post-transcriptional regulation of gene
expression. The rate of mRNA synthesis is not the sole determinant of mRNA, and the
1

mRNA decay rate is also a major determinant. Several mechanisms have been proposed
to describe how mRNA degradation takes place: decay can be preceded by shortening or
removal of the poly (A) tail at the 3' end or by removal of the m7G cap at the 5' end [6].
The turnover of an mRNA is widely regulated by cis-acting elements located in the 3'
UTR, such as the AU-rich elements (AREs), which promote mRNA decay in response to
cell signals. Degradation of mRNAs can also take place by endonuclease activity.
Endonucleolytic cleavage has been identified in the 3' UTR region which is targeted by
miRNAs. It has been recently reported that let-7 miRNA results in degradation of lin-41
target mRNA in C. elegans [7].
UTRs have a fundamental role in the control of RNA subcellular location, which is
particularly important during organism development. In many cases, mRNAs are
localized as ribonucleoprotein complexes along with proteins of the translational
apparatus, thus ensuring efficient localized translation. One example is 21-nucleotide
element in the 3' UTR of MBP mRNA, which are required for MBP mRNA transport and
localization [8].
In addition, UTRs play an important role in controlling mRNA translation efficiency,
in which 5’ UTR play a major role. Several cis-acting elements within 5’UTR, such as
upstream ORFs (uORFs), secondary structures or binding by specific proteins could be
involved in translation efficiency regulation. Recently, it was demonstrated that uORFs
reduce protein translation initiation levels by 30-80 %. After translation of the uORFs,
the large (60S) ribosomal subunit will be detached and the 40S small ribosomal subunit
may resume scanning, reinitiating with impaired translation efficiency of the main ORF.
An example has been reported for the yeast transcription factors GCN4 and YAP1 down2

regulation by uORFs [9]. Another alternative mechanism for translation initiation, which
allows translation of the RNAs in a cap-independent manner, is an internal ribosome
entry site (IRES). Cell may use IRES to increase translation of certain proteins during
mitosis. In mitosis, the cell dephosphorylates eIF-4E so that it has little affinity for the
5'cap. As a result, the pre-initiation mRNA loop is not formed, and the translational
machinery is diverted to IRES within the mRNA. Many proteins involved in mitosis are
encoded by IRES mRNA.
1.2 Biogenesis and Functions of miRNA
miRNAs are small ncRNAs that have been shown to function as key regulators of gene
expression and modulate many crucial biological processes, such as cell proliferation,
differentiation, and apoptosis in multicellular organisms [12-14]. miRNA genes are
transcribed as long primary microRNA (pri-miRNA), which is processed by Drosha and
its co-factor DGCR8 to generate precursor miRNA (pre-miRNA). Pre-miRNA is rapidly
exported to the cytoplasm by exportin-5 in a Ran–GTP-dependent manner, where it is cut
by Dicer to generate a mature approximately ~22 nucleotides long miRNA [10, 11].
Mature miRNAs are incorporated into argonaute proteins as guide sequence in the
assembling of miRNA-induced silencing complex (miRISC) for target-specific gene
silencing [15].
Small RNA Lin-4 was first reported miRNA as gene regulatory molecule in 1993 [16].
Plant miRNAs match their mRNA target complementarily to ensure irreversible cleavage
of target mRNAs and this is thought to be the predominant mode of miRNA mechanism
in plants [17]. In mammalian cells, miRNA: target pairing are rare and miRNA
3

recognizes mRNA targets with much shorter base pairs usually located at highly
conserved nucleotides at position 2 -7 of miRNA 5’ termini [18]. In mammalian cells, the
mechanistic details for miRNAs in repressing protein synthesis are still poorly
understood. miRNAs can affect both the translation and stability of mRNAs, but the
results from studies conducted in different laboratories have often been contradictory.
Earlier studies suggest that the miRNA-induced gene expression interference is through
binding to the 3’UTR of target mRNA and repressing translation. Recent studies suggest
that the mammalian miRNAs predominantly act to decrease target mRNA levels.
However, no direct evidence for miRNA-mediated target mRNA cleavage and
degradation has been demonstrated in mammalian cells [19]. The detection methods used
in those studies, i.e., 5’-RACE, PARE, Ribosome profiling, lacked the necessary
sensitivity to address the short lived nature of mRNA intermediates in detail especially
when there were only small portion of mRNA cleavages. With improved detecting
methods, those few cases of miRNA cleavages could just be the tip of iceberg.
Animal AGO proteins are essential for miRNA-directed target mRNA destabilization,
but insufficient for silencing. The study of the mechanism of miRNA-mediated mRNA
destabilization has been demonstrated in D. melanogaster. P‑body protein GW182,
which interacts with the miRNP Argonaute1, is a key factor that marks mRNAs for decay
[20, 21].
The CCR4-NOT complex and PAN2-PAN3 complex are two major enzyme complex,
which are responsible for mRNA deadenylation. Depletion of CCR4–NOT complex
prevents the decay-promoting activity of GW182, suggesting that GW182 plays a role in
recruiting CCR4–NOT to destabilize mRNAs [22]. It has also been reported that GW182
4

recruits the PAN2-PAN3 deadenylase complex through PAM2 motif [23]. In addition,
accelerated deadenylation results in a miRNA-induced degraded mRNAs in mammalian
cells. Widespread miRNA-mediated deadenylation of mRNAs occurs during zebrafish
embryogenesis, in which miR‑430 facilitates the destabilization of hundreds of mRNAs
by inducing their deadenylation and subsequent decay at the onset of zygotic
transcription [24, 25].

1.3 Roles of non-coding RNAs in Regulation of Gene expression
There are some other ncRNAs, which play important roles in cells. piRNAs (PIWIinteracting RNAs) are ncRNAs of 24–30 nt in length, binding the PIWI subfamily of
AGO proteins that are involved in target RNA repression. The complex, formed by
piRNAs and PIWI proteins, suppresses transposable element expression and
mobilization. snoRNAs (small nucleolar RNAs) are 60–300 nt in length ncRNAs, which
guide the site-specific modification of nucleotides in target RNAs through short regions
of base-pairing. SnoRNAs are composed of two major classes, the box C/D snoRNAs
which guide 2’-O-ribose-methylation, and the box H/ACA snoRNAs which guide
pseudouridylation of target RNAs [26, 27].
There is still considerable debate as to whether ncRNAs are functional or merely some
kind of ‘transcriptional noise’. It appears that the human genome express an enormous
repertoire of ncRNAs, which had been previously overlooked. We may have
fundamentally misunderstood the nature of genetic programming. Although the functions
of these ncRNAs are likely to be varied, the evidences strongly suggest that their main
role is to regulate and direct the complex pathways in cells [28].The extent of ncRNAs
5

conservation is also much higher than mRNAs, perhaps as high as 10% [29]. This
conservation includes ultra-conserved sequences [30] and long transposon-free regions
that have remained refractory to transposon insertions during evolution [31]. There are
probably many other functions of ncRNAs awaiting discovery. For example, the
observation that many ncRNAs are located in the cytoplasm suggests that they might
have undiscovered roles. There is increasing interest in the potential involvement of
ncRNAs in disease development, owing to aberrant function of ncRNAs in differentiation
and developmental processes. For example, an antisense ncRNA transcribed from the p15
tumor suppressor locus regulate local heterochromatin and DNA methylation status,
thereby down-regulating p15 expression, which is involved in oncogenesis in leukemia
[40].
1.4 Therapeutic Applications of miRNAs and miRNA-target Sites in Human
Cancers
miRNA is the most widely studied group of ncRNAs in human cancer. miRNA
expression profiles differ between normal cells and tumor cells, acting as oncogenes or
tumor suppressors [41]. One of the first reported associations between miRNAs and
cancer was miR‑15 and miR‑16 dysregulation in most B cell chronic lymphocytic
leukaemias as a result of chromosome 13q14 deletion [42]. Another intriguing example is
miR-200. CpG island hypermethylation-associated silencing of miR-200 in tumors upregulate the zinc finger E-box-binding homeobox ZEB1 and ZEB2, which, in turn, leads
to a down-regulation of E-cadherin, promoting epithelial-to-mesenchymal transition
(EMT) in cancer [43].

6

Antisense oligonucleotides (ASOs) are therapeutically widely used to inhibit miRNA
function. ASOs inhibit miRNA targets based on base-pair complementarity. There are
three main classes of ASOs, including locked nucleic acids (LNAs), anti-miRNA
oligonucleotides (AMOs) and antagomirs with chemical modifications to increase
stability and efficacy [44]. For example, the intravenous injection of antagomirs targeting
miR-10b prevents the onset of metastasis, suppressing dissemination to the lungs in the
mouse [45]. Another recent study reported the use of ‘miRNA replacement therapy’
strategy, restoring miR-26a expression in hepatocellular carcinoma. miR-26a was
delivered by an adenoviral vector in a mouse model of hepatocellular carcinoma,
resulting in suppression of proliferation and induction of apoptosis, thereby inhibiting
cancer progression [46].
In addition, certain features in UTR have been approved to be associated with tumor
genesis. BRCA1 (breast cancer 1) acts as a tumor suppressor and is involved in cell-cycle
checkpoints, apoptosis and DNA damage repair. BRCA1 protein expression is controlled
by an alternative 5’ UTR. BRCA1 has two promoters (α and β), encoding two 5’ UTR
differing in the length of the 5’UTR.The longer 5’UTR is found in breast cancer tissues,
whereas the shorter 5’UTR is found in normal breast tissues. The longer 5’UTR, being
more structured and having additional uAUGs, is translated 10-fold less efficiently than
the shorter 5’UTR. Thus BRCA1 expression is inhibited in breast cancers by longer
5’UTR. Therefore, BRCA1 promoter α (producing longer 5’UTR) can be an effective
target in breast cancer therapy [47].
There are many well characterized examples of UTRs that act as regulatory ncRNAs in
disease development. Another intriguing example is the ncRNA HSR1 (heat-shock RNA7

1), which forms a complex with HSF1 (heat-shock transcription factor 1), enabling the
transcription factor to induce expression of heat-shock proteins during the cellular heatshock response [23]. UTRs are the sensors of miRNAs by base-pairing mechanism. For
instance, SLITRK1 mRNA 3’UTR sequence variants in the binding site for the miR-189
have been shown to be associated with Tourette’s syndrome.
1.4 The purpose of this study
Interests in the contribution of ncRNAs to the genesis and progression of human
disorders are booming. However, there are still huge gaps in our study of ncRNAs,
including their function and mechanisms by which ncRNAs exert pathological effects. It
will be crucial to understand the mechanism how miRNA regulation of target mRNA
repression, which is the basis to miRNA research in mammalian cells.
One important challenge will be to identify all functional ncRNAs that are encoded in
the human genome. What is required, and is currently developing, is the application of
unbiased techniques, such as the Encyclopedia of DNA Elements (ENCODE) project,
which will identify all functional elements in the human genome [48]. Bioinformatics
tools for identifying potentially functional ncRNAs will also be important. Because
ncRNAs fold into complex secondary structures that are crucial to their function,
sequence-based alignments alone might not be enough to identify ncRNAs. A number of
algorithms have been developed to identify potentially functional ncRNAs (for example,
RNAfold, Pfold, CMFinder and Foldalign). To some degree, the studies of ncRNAs have
been delayed, which is because of the lack of appropriate laborious techniques to identify
these ncRNAs systematically. Identification of novel ncRNA occurred rather by chance
than by systematic screens.
8

With respect to disease, understanding the precise biological roles of ncRNAs is a key
challenge. For example, mouse model is a good model to study the specific function of
ncRNAs. A recent study of mouse model that conditionally express miR-21, revealed that
miR-21 as a genuine oncogenes [49]. Biochemical tools, such as antagomirs, have been
useful in elucidating the function of miRNAs, however, having its limitations. Some
other techniques have been developed, for example, rapid amplification of cDNA ends
(RACE) method was used to define the origin of transcription of T-UCRs, but the process
is very time consuming [50]. Therefore, advanced molecular biological and biochemical
tools and methods are much needed to efficiently and accurately identify non-coding
region RNA. Technical breakthroughs can bridge the gap between ncRNAs knowledge
and knowledge-based application in disease diagnosis and treatment.
In our study, we tried to study the transcriptional regulation of TUSC2. TUSC2 is a
novel tumor suppressor gene located in the human chromosome 3p21.3 region. TUSC2
mRNA transcripts could be detected on Northern blots in both normal lung and some
lung cancer cell lines, but no endogenous TUSC2 protein could be detected in a majority
of lung cancer cell lines. Mechanisms regulating TUSC2 protein expression and its
inactivation in primary lung cancer cells are largely unknown. We investigated the role of
the 5’-UTR and 3’-UTR of the TUSC2 gene in the regulation of TUSC2 protein
expression, as TUSC2 have very conservative and complex UTRs. We found that two
small uORFs in the 5’UTR of TUSC2 could markedly inhibit the translational initiation
of TUSC2 protein by interfering with the “scanning” of the ribosome initiation
complexes. In addition, there are miR-98, miR-93 and miR-197 directed cleavage sites on
TUSC2 3’TUR, which cause TUSC2 mRNA degradation.
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In addition, we tried to study the mechanistic details for miRNAs in repressing
protein synthesis. The established let-7 miRNA -targeted Hmga2 mRNA was used as a
model system to study the regulation of target mRNA by miRNAs in mammalian cells
under physiological conditions. In our study, we pointed out a direct link between mRNA
down-regulation and mRNA cleavages mediated by miRNAs, which were confused in
many years regarding miRNA mechanism study. The endonucleolytic cleavages on
Hmga2 target mRNAs were initiated by let-7 miRNA in seed pairing style have been
detected by our new developed SLA-RT-PCR. After that, the 5’ cleaved RNA fragments
were mostly oligouridylated at their 3’-termini and destroyed by mRNA 5’–3’
degradation. These findings warrant further investigation to identify the precise miRNA
targets in mammalians in endogenous context.

10

Chapter 2. Regulation of Novel Tumor Suppressor Gene TUSC2 Expression in
Human Lung Cancer Cells
2.1 Introduction
2.1.1 Lung Cancer and tumor suppressor gene
Lung cancer is the most common cancer in the world, with an estimate of 1.35
million new cases per year. Lung cancer kills more than 1.18 million patients each year,
as the leading cause of cancer death for both men and women. More than 85 % of lung
cancers are caused by tobacco smoke [51-53]. Studies of lung cancers have shown that
genetic alterations in the short arm of chromosome 3p are among the most frequent and
earliest genomic abnormalities. Moreover, the 3p21.3 region has been frequently detected
in smoke-damaged pre-neoplastic lesions. These findings suggest that one or more genes
in 3p21.3 region are tumor suppressor genes as molecular gatekeepers in lung cancers.
TUSC2 gene, also called FUS1, is one candidate tumor suppressor gene, located in
3p21.3 region [54-55]. Wild-type TUSC2 protein induces tumor cells G1 growth arrest
and apoptosis, suppresses tumor growth and inhibits lung metastases in mouse model.
TUSC2 induces apoptosis through the activation of the mitochondria-dependent and
Apaf-1 associated pathways and inhibits the tyrosine kinases function including EGFR,
PDGFR and AKT [56-60]. Enforced expression of TUSC2 in H1299 cells inactivated cAbl and its tyrosine kinase [61]. It also showed that expression of TUSC2 sensitized the
response of lung cancer cells to cisplatin, which was associated with the down-regulation
of MDM2 and increase of p53 [62].
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Squamous metaplasia and dysplasia express significantly lower levels of TUSC2
than normal and hyperplastic bronchial epithelia. Loss or reduction of TUSC2 protein
expression is associated with worse overall patient survival [60]. TUSC2-nanoparticles is
used in Phase I clinical trial for patients with chemotherapy refractory stage IV lung
cancers at the University of Texas M.D. Anderson Cancer Center. TUSC2 mRNA
transcripts could be detected on Northern blots in both normal lung and some lung cancer
cell lines, but no endogenous TUSC2 protein could be detected in a majority of lung
cancer cell lines. Only a few mutations in TUSC2 gene are found in human lung cancers,
and its promoter methylation is a rare phenomenon. Uno et al. showed TUSC2 is a
myristoylated protein and loss of myristoylation at the N-terminus cause TUSC2 protein
rapidly degradation. The defect of the TUSC2 protein was detected in primary lung
cancers [58]. However, mechanisms regulating TUSC2 protein expression and its
inactivation in lung cancers are largely unknown. Therefore, elucidation of mechanisms
regulating TUSC2 protein expression is important to control the loss of TUSC2 in the
early pathogenesis of lung cancer.

2.1.2 TUSC2 protein expression regulation
The regulatory events that govern gene expression are implemented at three levels:
transcription, post-transcription, and translation. The normal TUSC2 mRNA expression
in tumor cells suggests translational control of TUSC2 mRNA might inactivate TUSC2.
Although many features of mRNA can contribute to its translation, control elements are
mostly found in the un-translated regions of transcripts (UTRs), because UTRs are under
less pressure of sequence conservation and easily to form regulatory elements [63]. It is
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widely known that 5’UTR is responsible for translation initiation through start-site
consensus sequence as well as upstream AUGs [64]. 3’UTR regulates transcripts stability
and localization, which contains numerous binding sites for regulatory factors [65]. A
highly conserved and long complex TUSC2 UTRs suggests UTRs might play an
important role in regulation of TUSC2 protein expression. Here, we investigated the role
of the TUSC2 UTRs in the regulation of TUSC2 protein expression and detected the
regulatory mechanisms lead to the loss or reduction of TUSC2 expression in lung cancer
cell lines.

2.2 Methods and Materials
2.2.1 Cell lines and cell cultures
The human non-small cell lung cancer cell (NSCLC) line H1299, A549, H322 and
cervix Hela cells were obtained from American Type Culture Collection. H1299, A549,
H322 and Hela cells were grown in RPMI 1640 supplemented with 10% fetal bovine
serum in an atmosphere of humidified air containing 5% CO2. Normal human bronchial
epithelial (HBE) cells were obtained from Dr. John Minna’s laboratory. HBE cells were
grown in Keratinocyte-SFM medium (Invitrogen, Carlsbad, CA).

2.2.2 Preparation of plasmids
A 1772 nucleotides sequence region containing TUSC2 coding region bounded by
5’UTR and 3’UTR was cloned into pKGB2 plasmid. Following the same construction
procedure, 433 nucleotides (nts) 5’UTR-TUSC2 coding region, 1672 nts TUSC2 coding
region-3’UTR, 333 nts TUSC2 was cloned into each pKGB2 construct. We constructed
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four plasmids with the same backbone and different translated regions as follows:
5’UTR-TUSC2-3’UTR, 5’UTR-TUSC2, TUSC2-3’UTR and TUSC2. Figure 1 showed
schematic drawing of the four plasmids. All constructs were confirmed by DNA
sequencing.

FUS1

CMV

5’UTR-FUS1

CMV

FUS1-3’UTR

CMV

5’UTR-FUS1-3’UTR

CMV

FUS1-CDS
5’ UTR

Poly A

FUS1 CDS
5’ UTR

Poly A

FUS1-CDS

3’ UTR

FUS1-CDS

Poly A
3’ UTR

Poly A

Figure 1. Effects of UTRs of TUSC2 mRNA gene and protein expression in human
NSCLC H1299 and normal HBE cells. Schematic representations of TUSC2 expressing
constructs with or without intrinsic 5’UTR and 3’UTR. TUSC2 expression plasmid
constructs contain an expression cassette with a CMV promoter-FUS1 CDS-BGH polyA
signal (Reproduced with permission of BBRC 410(2):235-241).

2.2.3 Plasmid transfection
Cells were plated and cultured overnight, and then transfected with specified
expression vectors using DOTAP: cholesterol - encapsulated plasmid DNA nanoparticles.
In brief, 2 µL DOTAP: cholesterol reagent and 2 µg plasmid DNA were mixed, and the
mixture was added to each well in a six-well plate and incubated for indicated days. The
transfection efficiency was assessed by a parallel transfection with an equal amount of
green fluorescent protein (GFP)-expressing plasmid vector.

2.2.4 RNA isolation
For total RNA preparation, cells were grown on 6-well plates and approximately 2 x
106 cells were used to isolate the total RNA using the TRIzol reagent (Life Technologies,
14

Grand Island, NY) and phenol:chloroform extraction and ethanol precipitation according
to the manufacturer’s protocol. The isolated total RNA was stored in 70% ethanol at 80C.

2.2.5 Reverse-transcription and quantitative Real-time PCR
RNeasy Mini kit was used to isolate total RNA. RNA was treated with DNase I and
was reverse-transcribed using High Capacity cDNA Reverse Transcription Kit.
Quantitative real-time PCR was performed in triplicate for each reaction. Negative
control group using samples without reverse-transcribed was used to see if there is any
DNA contaminated in RNA isolation. Melting curve analysis confirmed a single PCR
product in each reaction. The nucleotide sequence of the primers as follows:
TUSC2 sense primer: 5’-TCAGAGGCAGCAGGAGCTGA-3’, TUSC2 anti-sense primer
:5’-CATAGAACATAGAGCCGCGG.
GAPDH sense primer: 5’-TGCACCACCAACTGCTTAGC-3’, GAPDH anti-sense
primer: 5’-GGCATGGACTGTGGTCATGAG.
GFP sense primer: 5’-TGAGCAAGGGCGAGGAGCTGTT-3’, GFP anti-sense primer:
5’- CACGCTGAACTTGTGGCCGT-3’.

2.2.6 Western blotting assay
Cell lysates were prepared by incubating cells in lamin/urea buffer on ice, and
centrifuged at 13,000 rpm for 10 min at 4°C. 50 μg cell lysate of each treatment were
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resolved by SDS-PAGE and transferred onto a polyvinylidene difluoride membrane.
TUSC2 protein was detected with rabbit anti-TUSC2 antibody. The following
monoclonal antibodies were used: anti-green fluorescent protein (GFP) antibody and antiβ-actin antibody (Clontech, CA).

2.2.7 Secondary structure prediction of RNA segments
The lowest free-energy secondary structure for TUSC2 RNA was predicted by
RNAfold software (www.tbi.unvivie.ac.at).

2.3 Results
2.3.1 Expression of TUSC2 is repressed by its UTR
To determine the UTR regulation for TUSC2 expression, we transfected H1299 cells
and HBE-KTR cells with four plasmids, which have the same backbone and different
translated region including TUSC2, 5’UTR-TUSC2, TUSC2-3’UTR, 5’UTR-TUSC23’UTR. In H1299 and HBE-KTR cell, UTRs down-regulate TUSC2 mRNA expression
significantly (P<0.05). In H1299 cell, compared with the transcripts from construct only
carrying TUSC2 coding sequence, the TUSC2 transcript level decreased significantly 3fold from 5’UTR-TUSC2 construct (P<0.05) and decreased significantly 10-fold from
TUSC2-3’UTR construct (P<0.05). In HBE-KTR cell, the TUSC2 transcript level
decreased about 2-fold from 5’UTR-TUSC2 construct and decreased significantly 4-fold
from TUSC2-3’UTR construct (P<0.05) (Figure 2). These observations indicated that
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5’UTR and 3’UTR decreased the abundance of TUSC2 transcripts, which was more
significant in tumor cells than in normal cells.
1.5

Relative gene
expression

1.5

H1299
1.0

1.0
0.5

*
0.0

HBEC

*

*
0.0

CDS

*

0.5

*

UTR 5'UTR 3'UTR

CDS

UTR 5'UTR 3'UTR

Figure 2. Effects of UTR of TUSC2 mRNA gene expression in human NSCLC H1299
and normal HBE cells. Real-time PCR analysis for effects of TUSC2 5’- and 3’-UTR on
the TUSC2 mRNA expression in HBE and H1299 cells. In both cases the TUSC2 RNA
expression for cells transfected with TUSC2 expression plasmid without UTR was set to
1. TUSC2 relative gene expressions were normalized to GFP levels. * means P< 0.05,
error bars denote standard error. (Reproduced with permission of BBRC 410(2):235-241)

After 48h transient transfection, the western blot results showed that both 5’UTR and
3’UTR down-regulated TUSC2 protein expression. 3’UTR inhibitory effect showed more
significant in tumor cell line H1299 than in normal cell line HBE-KTR, which is
correlated with mRNA transcripts changes regulated by 3’UTR (Figure 3). A band close
to molecular weight of TUSC2 was observed, however, this is a nonspecific band as it
was detected in H1299 which cannot express TUSC2. Thus studies using this TUSC2
antibody should be interpreted with caution.
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Figure 3. Effects of UTRs on FUS1 protein expression in H1299 and HBE cells by
Western-blot analysis. Western blotting analysis for TUSC2 protein expression in HBE
and H1299 cells transfected with TUSC2 expression plasmids with or without UTRs.
(Reproduced with permission of BBRC 410(2):235-241)

To further confirm these findings, we investigated whether the TUSC2 UTRs exert a
similar effect on the translation of GFP. We cloned TUSC2 5’UTR and 3’UTR into GFP
reporter plasmid to test regulation of TUSC2 UTRs on GFP translation. H1299 cells were
transiently co-transfected with the plasmids carrying GFP coding region with or without
TUSC2 UTRs and CMV promoter-RFP plasmid. CMV promoter-RFP plasmid was
added to test if plasmid transfection efficiency was the same in these two groups. 48 h
later, the presence of TUSC2 UTRs significantly inhibited GFP expression, confirming
that TUSC2 UTRs have sequence or secondary structure element inhibition on gene
translation (Figure 4).
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Figure 4. Repression of reporter GFP protein expression by FUS1 UTRs in H1299 cells.
(A) H1299 cells were co-transfected with either a CMV-GFP [a] or a CMV-5’UTR-GFP3’UTR [b] expression plasmid, together with a CMV-RFP expression plasmid, to
normalize GFP expression in these H1299 transfectants. GFP [a and b] and RFP [c and d]
protein expressions were visualized under a fluorescence microscope. (B) Quantification
of GFP expression in CMV-GFP and CMV-5’UTR-GFP transfectants, which was based
on RFP expression as transfection control. (Reproduced with permission of BBRC
410(2):235-241)
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2.3.2 TUSC2 translation is repressed by 5’UTR
TUSC2 5’UTR contains two small uORFs encoding an 8-amino-acid peptide
(uORF1) and another 6-amino-acid peptide (uORF2), which could inhibit the main ORF
translation initiation by interfering with the “scanning” of the ribosome subunit.
Therefore, we made three site-directed point mutation plasmids in 5’UTR-TUSC2 to
detect the funtction for these two uORF: the first plasmid is to mutate the first ATG to
AAG in uORF1 for eliminating uORF1; the second plasmid is to mutate the second ATG
to AAG in uORF2 for eliminating uORF2; the third plasmid is to mutate both ATG to
AAG in two uORFs for eliminating both uORFs (Figure 5).

5’UTR
start

Wt-FUS1
mRNA

uORF1

uORF2

gttt---gcaggttatggtagtgcggactgcggtgtgagcagagcggccacggggcccgccatgcgccggcggccctgacATG-----Mut-uORF1

Mut-uORF1
(mt1)

uORF2

gttt---gcaggttaaggtagtgcggactgcggtgtgagcagagcggccacggggcccgccatgcgccggcggccctgacATG-----uORF1

Mut-uORF2
(mt2)

FUS1 Translation
start site

Mut-uORF2

gttt---gcaggttatggtagtgcggactgcggtgtgagcagagcggccacggggcccgccaagcgccggcggccctgacATG-----Mut-uORF1

Mut-uORF2

Mut-uORF1-2
gttt---gcaggttaaggtagtgcggactgcggtgtgagcagagcggccacggggcccgccaagcgccggcggccctgacATG-----(2mts)

Figure 5. Regulation of TUSC2 5’UTR on FUS1 expression. Schematic representation of
TUSC2 expressing constructs with 5’UTR site-directed eliminations of uORFs. The
positions of the uORFs and their corresponding point-mutation constructs are indicated
by arrows. (Reproduced with permission of BBRC 410(2):235-241)
We transfected these plasmids into H1299 cells and HBE-KTR cells. Mutation of
uORFs significantly abolished the 5’UTR down-regulation function in TUSC2 protein
expression but not in mRNA transcripts, which suggests these two uORFs inhibit TUSC2
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expression through translational influence, but not transcriptional influence (Figure 6 and
Figure 7). The two uORFs inhibitory effect is constant in normal cell line HBE-KTR and
tumor cell line H1299, suggesting TUSC2 cannot express extensively in tumor and
normal cells, otherwise excessive TUSC2 give rise to cell cycle arrest and apoptosis.

Figure 6. Effects of uORFs in 5’UTR on TUSC2 protein expression in H1299 cell and
HBE cell. Western blot analysis of TUSC2 protein expression in HBE and H1299 cells
transfected with TUSC2 expression plasmids with or without uORFs (Reproduced with
permission of BBRC 410(2):235-241).
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Figure 7. Effects of uORFs in 5’UTR on TUSC2 RNA expression in H1299 cell and
HBE cell. * means P< 0.05, error bars denote standard error. Real-time PCR analysis of
TUSC2 protein expression in HBE and H1299 cells transfected with TUSC2 expression
plasmids with or without uORFs (Reproduced with permission of BBRC 410(2):235241).
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2.3.3 3’UTR regulation of TUSC2 expression
To elucidate which region of 3’UTR down-regulate TUSC2 expression, we performed
a series of deletion mutants of the 3’UTR. The mRNA structure prediction program
RNAfold software revealed that there are several hairpin-like stem elements in 3’UTR
with potential to form stable secondary structure. As shown in Figure 8, we deleted a
series of stable secondary structure: 334-504 nt, 764-1479 nt, 776-1102 nt, 1080 -1461 nt,
1183-1248 nt (Figure 8).
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(1-333)

SE1
(334-504)

SE2
(778-1102)

SE3
(1163-1246)

poly A signal
(1521-1526)
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FUS1 CDS- 3UTR
3'UTR (1221 bp)

3UTR-mut1
(334-504)
3UTR-mut2
(776-1102)
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Figure 8. Effects of 3’UTR regulatory elements on TUSC2 expression in NSCLC H1299
and normal HBE cells. Constructs of deletion mutants of TUSC2 3’UTR. Names, relative
locations, nucleotide sequence lengths, and putative regulatory 3’UTR sequence elements
of the deletion mutants in TUSC2 3’UTR are schematically illustrated. (Reproduced with
permission of BBRC 410(2):235-241)
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Figure 9. TUSC2 3’UTR and mutants secondary structure analyzed by RNAfold
software. (Reproduced with permission of BBRC 410(2):235-241)

Figure 9 indicated the 3’UTR secondary structure after a specific stem loop deletion.
After transfection of TUSC2-3’UTR containing 764-1479 nucleotides deletions in H1299
cell, TUSC2 protein expression was significantly increased, indicating that elements in
764-1479 nt are important for TUSC2 translation inhibition (Figure 10).
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Figure 10. Effects of the 3’UTR mutations on TUSC2 protein expression by western-blot
analysis. Expression of GFP was used to normalize the transfection efficiency in H1299
cells co-transfected with a GFP expression plasmid and individual FUS1-3’UTR deletion
mutants. (Reproduced with permission of BBRC 410(2):235-241)

We also observed TUSC2 mRNA level was increased after 764-1479 nt deletion
(Figure 11), which suggest 764-1479 nt affected TUSC2 mRNA expression. In addition,
deletion of 1080 -1461 nt can also increase TUSC2 protein expression, which indicated
that 1080 -1461 nt might have regulatory elements, contributing to 764-1479 nt inhibitory
function. TUSC2 3’UTR in H1299 cell shows more significant inhibition on TUSC2
expression than in HBE-KTR cell. Interestingly, Figure 10 showed removals of 764-1479
nucleotides in 3’UTR abolishes TUSC2 protein expression inhibition and RNA synthesis
inhibition by 3’ UTR in H1299 cell, but has no effect in HBE-KTR cell. This result
suggests 3’UTR repress TUSC2 expression in H1299 through 764-1479 nucleotides, but
has no effect in HBE-KTR cells (Figure 11). Thus we speculate that 764-1479
nucleotides in 3’UTR might have unique regulatory elements in tumor cells, which
contribute to reduction of TUSC2 protein expression in tumor cells compared to normal
cells.
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Figure 11. TUSC2 mRNA expression in H1299 and HBE cells transfected with TUSC2
3’UTR deletion mutants. Real-time PCR analysis of TUSC2 protein expression in HBE
and H1299 cells transfected with TUSC2 3’ UTR deletion plasmids. Effects of the
deletion at position 764–1476 (mut4) in the FUS1 30UTR region on FUS1 mRNA
transcription in the H1299 and HBE cells. * means P< 0.05, error bars denote standard
error. (Reproduced with permission of BBRC 410(2):235-241)

2.4 Discussion
Translation can be divided into three stages: initiation, elongation, and termination.
5’UTR is responsible for initiation of translation, which is the primary target of
translation regulation. Selection of the translation initiation site occurs via “scanning
mechanism”, which postulates that the small ribosome subunit scans linearly from the 5’
end of the mRNA; stopping when the first AUG codon is reached and forming an 80S
ribosome to start translation [66]. Several cis-acting elements within 5’UTR, such as
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uORFs, secondary structures or binding motifs bound by specific RNA binding proteins
could be involved in translational regulation. Recently, it was demonstrated that uORFs
reduce protein levels by 30-80 %. The translation repression by uORFs is associated
with: strong uAUG context, evolutionary conservation, increased distance from the cap,
and multiple uORFs in the 5’UTR. The 5’UTR of TUSC2 contains two uORFs; both of
the uORFs are nearly identical in mice, chimpanzee and humans, which suggests good
reservation. In addition, the uAUG of uORFs are far from the cap; and the 1st uAUG is
flanked by a guanine at position -3 and a guanine at position +4, and the 2nd uAUG is
flanked by a guanine at position -3 and a cytosine at position +4, and thus is in ‘adequate’
consensus context for uORF translation initiation start [67]. In agreement with this
prediction, the two uORFs influences significantly TUSC2 translation. Mutation of
uAUGs to uAAGs significantly up-regulate TUSC2 translation.
In addition, it was reported that stable stem loops with a free energy of -30 to -61
kcal/mol are sufficient to block ribosomal scanning in 5’UTR and therefore inhibit
translation. Based on RNAfold analysis, TUSC2 5’UTR display highly stable secondary
structure with the free energy of -72.18 kcal/mol, which might impede ribosome
scanning. As shown in Figure 6, the inhibitory function of 5’UTR cannot be all
attributable to uORFs. The 5’UTR stable secondary structure might contribute to the
TUSC2 translation initiation through blocking ribosomal scanning.
3’UTR regulate gene expression through mRNA 3’end processing, sub-cellular
localization and its stability. We also identified several regulatory elements or motifs in
the 3’UTR region of TUSC2 transcripts by serial deletions and biological
characterization of these 3’UTR deletion mutants in normal lung and lung cancer cells. It
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was reported that 3’UTR is “a molecular hotspot for pathology”, if disrupted, leads to life
threatening disease. TUSC2 has a highly conserved and long complex 3’UTR, suggesting
3’UTR might play a critical role in regulating TUSC2 expression. However, TUSC2
3’UTR lacks typical AU-rich elements, which are well-known targets for degradation. It
was reported that RNA binding proteins are involved in translational control of certain
gene by binding to secondary structure elements like stem loops in 3’UTR. Sequence
analysis revealed TUSC2 3’UTR has a series of stable secondary structure might be
involved in TUSC2 expression regulation. Our findings indicate that nucleotides 7641479 nt in 3’UTR are decisive in the control of TUSC2 RNA expression in tumor cells
and normal cells. However, precise structural elements and mechanism of repressive
action in 3’UTR remained to be clarified. The 3’UTR of TUSC2 has been shown to be a
target of other miRNAs including miR-93, miR-98, and miR-197 [136]. Down-regulation
of TUSC2 expression in both SCLC and NSCLC cell lines and primary tumors correlates
with elevated miR-93 and miR-197 expression [136]. The predicted miR-98 targeting site
is located in Δ334–504 region of 3’UTR. These results suggest that differentially
expressed miRNAs may target the 3’UTR of TUSC2 mRNA and act as negative
regulators of TUSC2 expression in lung cancers.
The results indicate that TUSC2 expression is tightly regulated. Because too much
TUSC2 could lead cell death and too little TUSC2 could promote tumor formation, it is
extremely important that TUSC2 expression needs to be strictly controlled. Firstly, for
the 5’UTR, two uORFs inhibitory effect is constant in normal cell HBE-KTR and tumor
cell H1299, suggesting TUSC2 cannot express extensively otherwise excessive TUSC2
give rise to cell cycle arrest and apoptosis. Secondly, for the 3’UTR, the stem loops
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down-regulate TUSC2 protein expression through affecting mRNA stability in H1299
cells, but not in HBE cells, which is responsible for the low-expression of TUSC2 protein
in tumor cells.
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Chapter 3. Detection of intermediates and end products of microRNA processing in
human cells by a novel Stem-loop Array RT-PCR
3.1 Introduction
3.1.1 microRNA biogenesis
MicroRNAs (miRNAs) are small non-coding RNAs that have been shown to function
as key regulators of gene expression at the posttranscriptional level and modulate many
crucial biological processes, such as cell proliferation, differentiation, and apoptosis in
multicellular organisms [68-75].

MiRNA genes are transcribed as long primary

microRNA (pri-miRNA), which is processed by Drosha and its co-factor DGCR8 to
generate precursor miRNA (pre-miRNA). Pre-miRNA is rapidly exported to the
cytoplasm by exportin-5 in a Ran–GTP-dependent manner, where it is cut by Dicer to
generate a mature miRNA [73,76-79] . The processed miRNA species are the production
of phased small RNA reads that consist of the most abundant form of the 22 nt-long
mature miRNAs, the less abundant miRNA isoforms, and other miRNA gene transcriptoriginated miRNA and transient miRNA sequences [76]. Despite the complex
compositions of these small RNA reads, there should be little variation in the RNA ends
corresponding to Drosha and Dicer processing sites and, in particular, it should have a
nearly uniform position at the 5′ ends of the RNA reads and a unique 2-nt overhang at the
3′ ends of miRNA duplexes [75]. An in depth analysis of tremendous amounts of these
small RNA reads could provide an opportunity for miRNA gene discovery but also poses
the big challenge in distinguishing authentic miRNAs from other types of small RNA

29

species and in quantifying the abundance and verifying the accurate sequence of a given
mature miRNA species in living cells [76,80,81].

3.1.2 Current methods used for detection of miRNAs
A number of methods are employed for sequence determination and expression
profiling of endogenous miRNAs. Cloning and Northern blotting are the standard
methods for miRNA sequence analysis, but such approaches require a large amount of
input RNAs [81,82]. Recently, microarray and bead based assays are used for highthroughput miRNA profiling for fast screening and comparative expression analysis of
miRNAs in biological samples, but have a limited sensitivity and specificity due to the
potential non-specific annealing inherent for hybridization-based methods [84-87].
Recent applications of deep sequence technology have greatly facilitated and simplified
the analysis of miRNAs and made the investigation of small RNA repertoires of cells
possible at the unprecedented resolution of hundreds of millions of reads [80, 81].
However the cost-intensive equipment and reagents and the complicated data process and
bioinformatics analysis of deep RNA sequencing may not practical or affordable for
routine miRNA analysis in majority of research laboratories. RT-PCR is a gold standard
for gene expression analysis [88] and exhibits a high degree of sensitivity and specificity
[89]. Chen et al. developed a TaqMan based stem-loop RT-PCR for a real-time
quantification of miRNAs and demonstrated a high sensitivity and specificity [90]. This
method, however, was designed to quantify a given miRNA with only one stem-loop RT
primer based on the predicted mature miRNA sequence but cannot verify and detect
processed mature miRNA species with variations or modifications at their 3’ and 5’ ends.
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Furthermore, the recent studies have revealed amazing complexity in the miRNAmediated regulatory mechanisms and biological functions, which involves multiple steps
of miRNA processing, target recognition, binding, and cleavage, and interactions with
other miRNAs, protein cofactors, and signaling pathways [72, 74-76]. To determine the
precise mechanism of action and better understand the regulatory function of endogenous
miRNAs in a complex biological system such as in mammalian cells,

advanced

molecular biological and biochemical tools and methods are much needed to efficiently
and accurately identify and quantitatively measure intermediates and end-products
resulted from the miRNA action in multicellular organisms under physiological
conditions.
For these purposes, we developed a novel stem-loop array reverse transcription
polymerase chain reaction (SLA-RT-PCR) approach to systematically verify and detect
the endogenous miRNAs and the target mRNA and DNA cleavage fragments by
accurately identifying their unique nucleotide ends generated during miRNA processing
and molecular action of siRNA and restriction enzymes (REs) in human cells. We used
the endogenous miRNA, the synthetic siRNA with an ectopically expressed mRNA target
template, and the REs with DNA templates as testing models to evaluate sensitivity,
specificity, and efficiency of the SLA-RT-PCR assay. Our results demonstrated the great
potential and broad applications of using the SLA-RT-PCR as a sensitive, cost-efficient,
and high-throughput tool to systematically determine the biogenesis and expression of
endogenous miRNAs and their mechanisms of action in multicellular organisms under
physiological conditions.
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3.2 Methods and Materials
3.2.1 SLA-Reverse-transcription
Reverse transcriptase reaction (RT) contains total RNA samples prepared from human
lung and cervix cancer cell lines and normal HBE cells. The RNA sample was briefly
treated with (0.04U/ µl as final concentration) RNAase-free DNAase I. RNA was
reversed transcribed using the High Capacity Reverse Transcription kit (Life
Technologies, Applied Biosystems) in combination with an array of stem-loop RTprimers. The 20 µl of RT reaction contains 50 ng of total RNA, 5×10-12 mol of SLA-RT
primer, 2 µl 10x RT buffer (Applied Biosystems), 1 µl Multiscribe reverse transcriptase
(Applied Biosystems), and 0.8 µl 100 mM of dNTP mix (Applied Biosystems). To
increase reverse transcription efficiency, a pulsed RT reaction was performed on a
DNAEngine Peltier Thermal Cycler (BIO-RAD) with 60 cycles at 18 °C for 1 min and 37
°C for 1 second, followed by 60 cycles at 20 °C for 1 min, 37 °C for 1 second, 37 °C for
30min, 42 °C for 20 min, 85 °C for 10 min, and then held at 4 °C.
3.2.2 SLA-PCR
For regular PCR, each cDNA sample generated from the SLA-RT reactions was
diluted 500 fold. The 20 µl of PCR reaction contains 1µl diluted RT product, 2 µl
10×standard PCR buffer, 0.8 µl 10mM dNTP, 0.5 µl 100mM MgSO4, 0.2 µl Taq
polymerase, 1µl 10nm of forward primer and 1µl 10nm of reverse primer. PCR reactions
were conducted as at 95 °C for 5 min followed by 35 cycles at 95 °C for 15 s, 61 °C for
30s, and 37 °C for 30s, and 72 °C 10 min, on DNAEngine Peltier Thermal Cycler (BIORAD).
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3.2.3 miRNA detection real-time PCR
For real-time RT-PCR, a Taqman® Real-time RT-PCR for miRNA detection kit was
used (Applied Biosystems). The 15 µl of RT reaction consisted of 7 µl master mix, 3 µl
5×RT stem-loop RT primer, and 5 µl RNA sample (20 ng). The 7 µl of master mix
contained 1.5 µl 10× RT buffer, 0.15 µl 100 mM dNTPs, 1µl 50 U/µl MultiScribe reverse
transcriptase, and 0.19 µl 20 U/µl RNase inhibitor. RT reactions were incubated for 30
min at 16°C, 30 min at 42°C, 5 min at 85°C, and then held at 4°C. The 20 µl of real-time
PCR included 1.33 µl RT product, 10 µl 2× TaqMan® Universal PCR Master Mix, 1 µl
TaqMan® small RNA assay, and 7.67 µl H2O. The reactions were incubated at 95°C for
10 min, followed by 40 cycles at 95°C for 15 s and 60°C for 1 min. The threshold cycle
(CT) is defined as the cycle number at which the FAM fluorescence signal passes the
fixed threshold, and were converted into relative miRNA expression by using U6 small
RNA as endogenous control.
3.2.4 SLA-RT-PCR product detection by agarose gel electrophoresis
PCR products resulting from SLA-RT-PCR were analyzed by agarose gel
electrophoresis in 1x Tris-borate-EDTA (TBE) buffer containing 89 mM Tris Base, 89
mM Boric Acid, and 2 mM EDTA, pH 8.0. TBE buffer was useful for separation of
smaller DNA fragments because it has a greater buffering capacity and gives a sharper
resolution than that of TAE buffer.
3.2.5 Fluorescence-based DNA fragment size analysis
In many of our SLA-RT-PCR products the sizes of non-specific primer dimmers are
similar to PCR products and it is difficult to distinguish them by size from agarose gel.
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Therefore, a fluorescence-based DNA fragment size analysis (FBFSA) [41] was
performed to accurately determine differences between non-specific and specific PCR
products. Fluorescently labeled fragments were detected using the Applied Biosystems
3730 Genetic Analyzer and the size of each PCR fragment was determined using
Genotyper analysis software by comparing it with the standard curve for that specific
fragment lane. Accuracy of less than one base difference could be seen between sample
replicates. Higher throughput can be achieved by multiplexing different dyes and
fragment sizes together.

3.3 Results
3.3.1 SLA-RT-PCR
We developed a novel SLA-RT-PCR technique to systematically verify and detect the
endogenous mature miRNAs and the intermediate mRNA fragments cleaved by siRNA
by accurately identifying their unique nucleotide ends generated during miRNA
processing and by siRNA-mediated target cleavage in human cells. The SLA-RT-PCR
assay includes two steps: SLA-RT and PCR. The principle of works, experimental
design, and assay procedures are illustrated in Figure 12. The stem-loop-array RTprimers comprise two unique sequence components: a short single-stranded stretch (6
bases) at the 3’ end of the primer oligonucleotide that is miRNA-specific and hybridizes
to the end of mature miRNA and a double stranded stem at the 5’ end that forms stemloop to function as a forceps to stabilize the secondary structure of the primer. The
specific sequences of the mature miRNA is recognized by the six-nucleotide
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complementary extension at the 3’ends of the RT-primer array, which can efficiently
reverse transcribe the miRNA into cDNA (Figure 12, Step 1). The use of an array of
stem-loop RT primers allows to accurately recognizing and verifying unique ends of the
RNA or DNA fragments processed by endonucleases. If the SLA-RT primers have no
perfect match, on both the length and the base, to the sequence of the 3’ or 5’ end of a
RNA fragment the efficiency of RT reaction will be dramatically reduced. The size and
relative amount of SLA-RT-PCR products can be detected by agarose gel electrophoresis
or a quantitative real-time RT-PCR. For subsequent PCR (Figure 12, Step 2) it is
proceeded with a pair of forward and reverse primers that contain antisense sequence
complementary to the 5’-end of miRNA and to the 3’-end of the stem loop of RT- primer,
respectively.
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miRNA
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Stem-loop-Array RT
primers
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High RT
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lower RT
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Nestled-PCR
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Figure 12. Schema of SLA-RT-PCR assays for miRNA detection and verification. The
SLA-RT PCR assay includes two steps: SLA-RT and PCR. The stem-loop-array (SLA)
RT-primers bind to the ends of mature miRNAs. Specific sequences of mature miRNA
species are recognized by the six-nucleotide (nt) complementary extension at the 3’- or
5’-ends of SLA-RT primers, which can reverse transcribe the miRNA into cDNA with
varied efficiency (Step 1). The highest RT efficiency and specificity will be detected in
RT reactions with SLA-RT primers containing 6-nt stem sequences perfectly matched to
those at ends of the mature miRNA will exhibit and a dramatically reduced efficiency
(10-100 fold less) and specificity will be noticed in RT reactions with SLA-RT primers
having no perfect matches or mutations. The subsequent PCR (Step 2) is preceded with a
pair of forward and reverse primers that contain antisense sequence complementary to the
3’ or 5’ end of miRNA and to the 5’ or 3’-end of SLA-RT primer, respectively.
36

3.3.2 Verification of 3’ ends of synthetic RNU44 RNA and DNA fragments by SLART-PCR
We first used synthetic small RUN44 RNA or DNA templates as model systems to
evaluate the SLA-RT-PCR for detection and verification of the 3’ end of RUN44 RNA
and DNA fragments. RNU44 is a member of abundant intronic small-nucleolar RNAs
that were frequently used as reference genes for measuring endogenous miRNA
expression [75]. It has a predicted RNA sequence of 66 nucleotides (Figure 13). We
designed 12 SLA-RT-primers that are different by one nucleotide from each other
(Figure 13) and performed SLA-RT-PCR reactions using synthetic RNU44 RNA and
DNA as templates and analyzed SLA-RT-PCR and SLA-PCR products, respectively, by
agarose gel electrophoresis (Figure 14).

37

Figure 13. Detection and verification of 3’ and 5’ ends of synthetic and endogenous
small nucleolar RNU44 RNAs by SLA-RT-PCR. A, The predicted full length RNU44
RNA sequences with 5’ and 3’ end sequences (underlined) targeted by SLA-RT-5’primers and SLA-RT-3’- primers, respectively.
As expected, the SLA-RT primers ending in AGTCAG (primer 1), GTCAGT (primer
5), TCAGTT (primer 6), TGTCAG (primer 9), and AGTCAGT (primer 10) that process
perfect or near perfect match to the 3’end sequences of RUN44 successfully reversetranscribed RNU44 RNA with a high efficiency. However, the RT primers with
mutations at 3’ end or in the middle of RT-primer sequences, including AGTCAC
(primer 2), AGTCTC (primer 3), AGTGTC (primer 4), TCACAG (primer 7), AGTGTG
(primer 11) and AGAGTG (primer 12), could not reverse-transcribe RNU44 or showed
dramatically reduced efficiency (Figure 14, panel I). Similar results were also
demonstrated in PCR reactions with same primer sets using RNU44 DNA as a template
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with either the same nucleic acid sequences corresponding to RNA sequences (Figure 14,
panel II) or with one base (T) added at the 3’-end (Figure 14, panel III). The predicted
sizes and sequences of the SLA-RT-PCR products with primers 1 (AGTCAG), 5
(GTCAGT), 6 (TCAGTT), 9 (TGTCAG), and 10 (AGTCAGT) (primer 10) were further
confirmed by fluorescence-based fragment size analysis (FBFSA) (Figure 16, Array I)
and DNA sequencing (Figure 16), respectively. These results indicate the high specificity
of the designed SLA-RT primers to the 3’ end sequences of RNA or DNA fragments.

Figure 14. Detection and verification of 3’ ends of synthetic RNU44 RNA (I, 44nt) and
(II, 45 nt) and DNA (III, 61 bp) and (IV, 62 bp) templates by SLA-RT-3’-primers (Fig
13) on agarose gels. Sequences of synthetic RNU44 RNA and DNA templates are
described at the bottom of gel graphs and the predicted specific SLA-RT-PCR products
are indicated by arrows on the left sides of gels.

3.3.3 Detection and verification of 3’ and 5’ ends of endogenous RNU44 RNAs in
H1299 Cells
We used two sets of SLA-RT-primers to detect and verify the 3’ and 5’ ends of
endogenous RNU44 RNAs in H1299 cells (Figure 15). The same set of 3’ SLA-RT
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primers as shown in Figure 13 (SLA-RT 3’-primers) was used to detect the 3’ end of
RUN44 RNA in H1299 cells (Figure 15, panel I). Similarly, the RT products of RNU44
were detected with a high efficiency in RT reactions containing primers 1, 5, 6, 9, and 10
but were not detectable in RT reactions with mutation-bearing primers 2, 3, 7, 11, and 12
or detected in dramatically reduced efficiency with primers 4 and 8, respectively (Figure
15). The sizes and sequences of these 3’-SLA-RT products amplified from endogenous
RNU44 RNAs were further confirmed and verified by both FBFSA and DNA sequencing
(data not shown). These results indicate that a large population of RNU44 RNAs
expressed in H1299 cells is ended with sequences of ACUGAC at their 3’ ends but
without the predicted U (Figure 13) at their termini.

Figure 15. Detection of 3’ and 5’ ends of endogenous RNU44 RNAs in H1299 cells by
SLA-RT-PCR on agarose gels, using two sets of SLA-RT primers shown in Figure 13
and run in TBE buffer. The predicted specific SLA-RT-PCR fragments are indicated by
arrows on the left sides of gels.
We also used a set of 5’-SLA-RT primers to detect and verify the 5’ ends of
endogenous RNU44 RNAs in H1299 cells (Figure 15, panel II).

The 5’-RT-PCR

products amplified from endogenous RNU44 RNAs were detected with a high efficiency
in RT reactions containing 5’-SLA-RT primers 13 (CCTGGA), 19 (CTGGAT), and 20
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(TGGATG) with perfectly matched complementary sequences to the 5’ ends of RNU44,
but were not detectable in RT reactions containing RT primers 14 to 18 and 21 to 24 with
mutations at 3’ end or in the middle of the RT primer (Figure 15). The 5’-SL-RT primer
#19 ending in CTGGAT reversely transcribed RNU44 with the highest efficiency
(Figure 15, panel II). The sizes and sequences of these 5’-SLA-RT products amplified
from endogenous RNU44 RNAs were further confirmed and verified by both FBFSA
(Figure 16, FDFSA profiles/5’-SLA-RT-PCR) and DNA sequencing.

These results

suggest that a large population of RNU44 RNAs in H1299 cells is ended with sequences
of CUGGAU at their 5’ ends but without the predicted nucleotide “C” (Figure 13) at
their 5’-termini. Together, these results indicate the high specificity and efficiency of
SLA-RT-PCR in detection of both 3’ and 5’ ends of endogenously expressed or
processed RNA fragments.
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A

B

Figure 16. Verification of SLA-RT-PCR products. (A) Verification of sizes of SLA-RTPCR products by fluorescence-based fragment size analysis (FBFSA). Representative
FBFSA profiles corresponding to individual 3’ SLA-RT primers (left panels) and 5’
SLA-RT primers (right panels). The verified sizes of specific SLA-RT-PCR DNA
fragments are indicated by arrows. (B) Confirmation of identities of specific SLA-RTPCR fragments by DNA sequencing. Representative DNA sequencing histograms are
shown in SLA-RT-PCR reactions with synthetic RNU44 RNA templates and
corresponding SLA-RT primers as indicated on the top.

3.3.4 The dynamic range and sensitivity of SLA-RT-PCR
To evaluate the dynamic range and sensitivity of the SLA-RT-PCR assay, we used two
synthetic small RUN44 RNAs as templates. The RNU44 RNA template I (Figure 17)
contains the predicted full 66-base sequences ending with “U” at the 3’ terminal and the
template II (Figure 17) contains the verified RNU44 RNA sequences without “U” at the
3’ end. SLA-RT primer was used to specifically detect the 3’-end of RNU44 RNA
templates I and II. Synthetic RUN44 RNAs were quantified based on the A260 reading
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and made a series of dilution over a range of eleven orders of magnitude from 10-18 to 1028

mole (Figure 17). SLA-RT primer could successfully reverse-transcribe the RNU44

RNA template A (Figure 17). However, as expected, a reduced RT efficiency was
observed in SLA-RT-PCR reactions because of the one-base over the reach by this stemloop primer at the 3’end of RNU44 RNA template II (Figure 17). These results further
demonstrated the specificity of SLA-RT-PCR assay.

5’
RT-Primer

G
GTCGAATTCAGTGCG

GACTGA- CAGCTTAAGTCACGC T

C C
G T
G

T

A
G
G
A T

Figure 17. Dynamic range and sensitivity of the SLA-RT-PCR assay. The SLA-RT-PCR
reactions were performed using SLA-RT primers and known concentrations of input
synthetic RNU44 RNA templates I and II over ten orders of magnitude from 10-18 to 10-28
mole. The specific SLA-RT-PCR products were analyzed by agarose gel electrophoresis
(upper panels) and corresponding liner regression plots of the log RNA template input
(mole) vise the relative output of SLA-RT-PCR products are presented in lower two
panels.
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The SLA-RT-PCR assay showed an excellent linear output of RT-PCR products
corresponding to the input of RNA templates over a dynamic detection range at lease of
five orders of magnitudes (from 10-18 to 10-22 mole) and demonstrated an extremely high
sensitivity that is capable of detecting as few as 10-22 mole in PCR reactions with both
RNU44 RNA templates and specific SLA-RT primers on agarose gel (Figure 17).

3.3.5 Detection and verification of 3’-end of mammalian miR-98 in mammalian cells
We used a human hsa-miR-98 as a model miRNA molecule to evaluate the SLA-RTPCR assay for detecting and verifying the 3’-ends of endogenous miRNAs in human cells
(Figure 18). The hsa-miR-98 is a member of let-7 miRNA family and its structure and
function have been extensively investigated in multi-organisms. The predicted secondary
structure

and

mature

sequences

of

pri-miR-98

from

miRBase

data

base

(http://www.mirbase.org) [94] is shown in Figure 18A. We designed 9 SLA-RT-primers,
which are complementary to the 3’ end of miR-98 (Figure 18B).

A

B

Figure 18. Detection and verification of mature miR-98 species in human cells by SLART-PCR. (A) Predicted secondary structure of has-miR-98. The mature miR-98
sequences are presented in red. (B) SLA-RT 3’-primers for detection of 3’-ends of mature
miR-98 and corresponding sequences of cDNA fragments by RT reactions.
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The endogenously expressed and processed mature miR-98 RNAs showed predicted
sequence reads at their 3’ ends with varied levels of distribution in H1299 cells, as
demonstrated by specific SLA-RT-PCR fragments in RT-PCR reactions containing SLART primers 6, 7, 8, and 9 and by an increased level of distribution of mature miR-98
species detected in reactions containing SLA-RT primers 6 to 9 (Figure 19). Similar
results to those shown in Figure 19 were also obtained in exogenously expressed and
endogenously processed mature miR-98 RNAs in H1299 cells, using the same set of
SLA-RT primers (Figure 19). These results demonstrate the reliability and accuracy of
the SLA-RT-PCR in detection and verification of end reads and levels of processed
mature miRNA species in mammalian cells.

Figure 19. SLA-RT-PCR detection of miR-98 in H1299 cell. PCR corresponding to
individual SLA-RT primers was shown in Figure 18. The predicted size of specific SLART-PCR is indicated by arrow on the left side. MK, molecular marker, NC, negative
control. SLA-RT-PCR reactions without SLA-RT primer was used as a control.
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Figure 20. SLA-RT-PCR detection of miR-98 in Hela cells with (+) or without (-)
exogenous transfection of miR-98 gene expressing plasmid. PCR corresponding to
individual SLA-RT primers was shown in Figure 18. The predicted size of specific
SLA-RT-PCR is indicated by arrow on the left side.
Based on these SLA-RT-PCR results of the distribution of mature miR-98 RNAs in
H1299 cells, we compared the distribution and expression levels of endogenous miR-98
RNAs among normal bronchial epithelial HBE, NSCLC H1299, and cervix cancer Hela
cells with or without the ectopic expression of miR-98, using above tested SLA-RT
primers 6-9 (Figure 21A). Different levels of expression and distributions of mature
miR-98 species were observed in different cells and cell lineages (Figure 21A).
Particularly, the mature miR-98 species with 3’-end in “CAACAA” detected by RT
primer #6 showed lowest distribution across all these cell lines and a highest level of
miR-98 expression could be detected in RT-PCR reaction using RT primer #9 in H1299
cells, whereas the highest level of mature miRNA species were detected using primer #8
in HBE and Hela cells (Figure 21A). For comparison, we also performed a quantitative
real-time SL-RT-PCR to determine the expression of miR-98 in these cells using an
Applied Biosystems SL-qRT-PCR miRNA detection kit, which contains one SL-RT
primer with similar sequences to those of our SLA-RT primer #6 (Figure 21B).

The

quantitative real-time SL-RT-PCR results exhibited a similar trends and magnitudes of
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miR-98 expression in these cells to those detected by SLA-RT-PCR using RT primer #6
(Figure 21B and C).

A

B

C

Figure 21. The distribution and expression levels of endogenous miR-98 RNAs among
normal HBE, H1299, and Hela cells. (A) A highest level of miR-98 expression could be
detected in using RT primer #9 in H1299 cells, whereas the highest level of mature
miRNA species were detected using primer #8 in HBE and Hela cells. (B) Relative
distribution of mature miR-98 species detected by SLA-RT primers #6, 7, 8, and 9,
respectively, in human HBE, H1299 and Hela cells. (C) Detection and quantification of
endogenous miR-98 by a quantitative real-time SL-RT-PCR miRNA detection assay
(Applied Biosystem).
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These results further confirmed by FBFSA and DNA sequencing (data not shown) and
clearly demonstrated the accuracy and advantage of SLA-RT-PCR assay in verification
and detection of different mature miRNA species in different cell lines or organisms over
the current SL-RT-PCR assay with a fixed SL-RT primer for a given miRNA.

Figure 22. Effects of RT temperature on the specificity and efficiency of SLA-RT-PCR
reactions in detection of mature miR-98 species in HBE, Hela and H1299 cells. PCR
corresponding to individual SLA-RT primers was shown in Figure 18. SLA-RT reaction
was performed at 20 C (A), 18 C (B) and 14 C (C).
Furthermore, we evaluate the effects of RT temperature on the specificity and
efficiency of SLA-RT-PCR reactions in detection of mature miR-98 species in human
normal bronchial epithelia and tumor cells (Figure 22). We generally performed a SLART reaction at 20 C as a standard RT temperature. An increased amplification of both
the specific and the non-specific RT-PCR products was observed when RT temperature
was lowered from 20 C to 18 C or 14 C. The patterns of SLA-RT-PCR corresponding
to individual SLA-RT primers, however, remained unchanged in reactions with varied
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RT temperatures. These results further confirmed the specificity and reproducibility of
the SLA-RT-PCR assay.

3.3.6 Verification and detection of the site-specific DNA cleavage by restriction
endonucleases
Restriction endonucleases (REs) are endonuclease that can cleave double-stranded (ds)
DNAs at specific sites and generate cleaved DNA fragments with unique 3’ and 5’
overhangs with defined length and bases. We used the well-defined restriction cleavage
sites and patterns on DNA templates as model systems to evaluate the potential of using
SLA-PCR assay to determine and verify the actual cleavage sites and the cleaved DNA
fragments by endonuclease RE activities. The RE Kpn I recognizes the palindromic
double-stranded DNA sequence 5’-GGTACC-3’ and cleaves DNA by generating a 4base 3’-overhang; and the Acc651 is an isoschizomer of Kpn I, recognizes the same DNA
sequence but produces DNA fragments that have a strictly 4-base 5’-overhang (Figure
23A). We used a SLA-PCR strategy, which applies the same principle of works as the
SLA-RT-PCR, to precisely map the actual cleavage sites by Kpn I and Acc651 by
detecting and verifying the 3’- and 5’ overhangs of the intermediates and final products
of RE reactions on DNA templates (Figure 23B and C). The Acc651 exhibited a
stringent RE cleavage pattern that generates RE DNA fragments predominantly with 5’AGCTCG overhangs, as amplified by the specific SLA-primer ending in “CGAGCT”
(Figure 23B, primer 10 and Figure 23C). In contrast, the Kpn I showed a promiscuous
RE activity, generating a mixture of RE DNA fragments with random cleavage sites
(Figure 22B and C). These results clearly demonstrate the sensitivity and specificity of
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SLA-PCR in detecting and verifying the intermediates and products of endonuclease
activities.

A

B

C

Figure 23. Detection of the site-specific DNA cleavage by restriction endonucleases
KpnI and ACC65I. (A) The restriction endonuclease map by KpnI and ACC65I. (B) SLA
-PCR strategy to detect the actual cleavage sites by KpnI and ACC65I. (C) SLA -PCR
precisely map the actual cleavage sites by Kpn I and Acc651 by detecting and verifying
the 3’- and 5’ overhangs of the intermediates and final products of RE reactions on DNA
templates
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3.3.7 Detection and verification of siRNA-mediated mRNA cleavage site by SLART-PCR
To further evaluate the potential application of SLA-RT-PCR assay in identifying
novel miRNA targets and molecular mechanisms of action, we used the siRNA-mediated
target mRNA cleavage as a model system to precisely detect and verify the intermediates
and end products of the siRNA activity in mammalian cells under physiological
conditions. It has been shown that mammalian siRNAs (21 and 22 nt) silence gene
expression by cleaving their target mRNAs for the sequential degradation and the siRNA
cleavage site on the mRNA target is usually located in the middle of the region spanned
by the siRNA duplex, following a canonical pattern of 10 bp from the 5′-end of siRNA in
the RNA-induced silencing complex (RISC) [95]. The RISC-associated argonaute 2 (Ago
2) protein cleaves the target mRNA into two distinct fragments: a 5′ fragment with a 3′
hydroxyl group, and a 3′ fragment with a 5′ phosphate. The 5’ fragment can be amplified
using SLA-RT-PCR with 3’-SLA-RT primers. We used a Dharmacon siRNA transfection
reagent (Dharmacon, Chicago, IL) to deliver a synthetic siRNA that was derived from
mature hsa-miR-98 and transfected a plasmid vector expressing hsa-miR-98 gene as the
siRNA target template into H1299 cells to determine the siRNA cleavage products by
SLA-RT-PCR (Figure 24). The miR-98-siRNA-mediated cleavage site on the miR-98
mRNA target was precisely detected by the SLA-RT-PCR in the middle of mature miR98 region at the predicted position “G”, which is 10 bp from the 5′-end of siRNA duplex,
as shown in Figure 24A and indicated by arrow. The identity of the SLA-RT-PCR
products was further verified by DNA sequencing (Figure 24B and 24C).
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Figure 24. Detection of siRNA cleavage site by SLA-RT-PCR assay. (A) The predicted
size of SLA-RT-PCR fragment amplified by SLA-RT primer #16. (B) sequences of
siRNA and its target and SLA-RT primers. The sequences of the SLA-RT primer (#16)
anticipated for efficiently detecting the predicted siRNA cleavage site on target RNA
template is underlined. (C) Detection of siRNA cleavage site in H1299 cells cotransfected with siRNA and target RNA expressing plasmids by SLA-RT-PCR. (D) DNA
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sequencing confirmation of the siRNA cleavage site and the cleaved RNA fragment
detected by SAL-RT-PCR.
These result clearly demonstrated the potential applications of SLA-RT-PCR in
identifying authentic miRNA targets and determine their mechanisms of action by
precisely detecting and verifying the cleavage sites on target mRNAs mediated by
miRNAs in the Ago 2-mRISC in mammalian cells under physiological conditions.

3.4 Discussion
Since the initial discovery, more than 1000 miRNAs have been experimentally
identified

or

predicted

by

computational

methods

in

human

genome

(http://www.mirbase.org) [94]. Different sets of miRNAs have been found to be
expressed in different organisms, tissue and cell types [76,82,96] and they may target
about 60% of mammalian genes [74, 97]. Consequently, great efforts have currently been
attributed to identify miRNA biomarkers and signatures associated with various human
diseases including cancer and to explore their biological roles and therapeutic potentials
[77, 98, 99]. These studies will greatly benefit from accurate identification and
quantification of endogenous miRNAs and determination of precise mechanisms of their
action.
The mature miRNA molecules have been shown to be varied in length and base
compositions or have modifications at their ends [100]. Accurate determination,
verification and quantification of miRNAs in a complex biological system are technically
challenging but essential for a better understanding of biological roles of miRNAs in
regulation of gene expression and disease pathogenesis. The currently used approaches
for miRNA profiling, detection, and quantification rely on the miRNA sequence data
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presented in various miRNA databases such as miRBase, which are neither accurate nor
complete in representing variations and modifications of endogenous miRNAs in a
specific organism and cell type. The small size and the complexity of mature miRNA
reads present a unique challenge for the conventional RT-PCR-based miRNA detection
and quantification methods. Chen and colleagues developed a TaqMan based stem-loop
RT-PCR for a real-time quantification of miRNAs and demonstrated a high sensitivity
and specificity [90]. This method was, however, designed to quantify a given miRNA
with only one pair of primers based on the predicted mature miRNA sequence but it
cannot verify and detect processed mature miRNA species with the unique and specific
3’ end and 5’ ends directly processed from their pre-miRNA sequences and overlooked
the critical distribution patterns of processed miRNA repertoires in a given biological
system. As demonstrated in this study, mature miR-98 species showed different
distribution and levels in different cell types and lineages and the different miRNA
molecules with different processed ends could clearly be identified and detected by SLART-PCR assay with miRNA end-sequence specific SLA-RT primers. The miR-98
molecules with 3’-end in “CAACAA” showed a lowest distribution while miR-98
molecules with 3’-end in “CAATAC” exhibited highest level in H1299 cells. In contrast,
a very low level of miR-98 expression was detected by a commercially available
quantitative real-time SL-RT-PCR because its fixed SL-RT primer can only detect the
miR-98 species that showed the lowest distribution in H1299 cells, as detected by one of
SLA-RT primers. Such results from conventional SL-RT-PCR can be misleading in data
interpretation regarding to the miRNA expression status. Our results clearly demonstrated
the accuracy and advantage of SLA-RT-PCR assay in verification and detection of
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different mature miRNA species in different cell lines or organisms over the current SLRT-PCR assay with a fixed SL-RT primer for a given miRNA, which overlooks the
importance of the significantly-varied distribution of mature miRNA species in different
cell types or organisms. The SLA-RT-PCR assay also showed an excellent linear output
of RT-PCR products corresponding to the input of RNA templates over a dynamic
detection range at lease of four orders of magnitudes (from 10-15 to 10-18 mole) and
demonstrated an extremely high sensitivity that is capable of detecting as few as 10-21
mole in PCR reactions.
We used an agarose gel electrophoresis and gel staining with ethidium bromide to
separate and detect the SLA-RT-PCR products. However, it is very difficult to use this
method to distinguish non-specific bands from specific RT-PCR products when their
sizes are small and similar. Thus, we used a fluorescent-based fragment size analysis
(FBFSA) to more accurately measure the size of PCR products. The FBFSA
demonstrated that the SLA-RT-PCR could successfully verify sizes of SLA-RT-PCR
products by precisely detecting 3’ and 5’-ends of mature miRNAs based on pre-miRNA
sequences. Many current studies addressing the role of miRNAs in various human
diseases including cancer have emphasized the need for accurately determining the
sequences of large numbers of miRNAs [97, 100]. However, it has been a persisted
challenge to verify sequences of small miRNAs with an averaging ~ 22 nt in length. Our
study convincingly demonstrated the potential of using SLA-RT-PCR method as a
sensitive and efficient biochemical and molecular tool to verify end sequences and
authentic species of endogenous miRNAs in mammalian cells.
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Endonucleases such as restriction enzymes (REs) are widely-used molecular biology
tools. We used the SLA-PCR assay to detect and verify RE activities of two RE
isoschizomers, Kpn I and Acc651, under stringent and relaxed restriction reaction
conditions. The SLA-PCR results provided first-handed molecular evidence confirming
those previous findings shown that the Kpn I could introduce unpredicted cuts in the
plasmid vector and the DNA insert and that the Acc65I offered more stringent restriction
cutting patters than the Kpn I and are more desirable for conditional cloning [103]. Our
results clearly demonstrate the sensitivity and specificity of SLA-PCR in detecting and
verifying the intermediates and products of endonuclease activities.
The cleavage and process of dsRNAs, such as siRNA, pre-miRNAs, and siRNA- or
miRNA-target mRNA duplexes, have been shown to be mediated by an intrinsic
endonuclease activity of argonauta (Ago) enzymes [94-109]. However, no confirmative
evidence has been commonly reported to demonstrate the actual mRNA cleavage events
mediated by siRNA-Ago2 activities in the RISC. Such efforts might partly been hindered
by technic difficulties in detecting and verifying the cleavage sites and the cleaved
mRNA intermediates and end products. The therapeutic applications of using siRNAs to
silence the pathogenic genes in clinical practice have also been hampered by their offtarget effects and difficulties in confirming that the observed mRNA knockdown is the
direct result of an RNAi-mediated event [110]. RACE (rapid amplification of cDNA
ends)-PCR and molecular cloning are commonly used to study the siRNA-Ago2
mediated target mRNA cleavage activities but these methods are very time-consuming
and labor-intensive [111]. The new SLA-RT-PCR technique presented in this study takes
advantages of the high fidelity of SLA-RT primers in recognizing the specific ends of
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DNA and RNA fragments generated by REs and siRNA-Ago2 activities, respectively,
and the sensitivity of PCR to efficiently and precisely detect target mRNA cleavage sites
by siRNAs, suggesting that the SLA-RT-PCR could be used to confirm that the siRNAmediated mRNA cleavage mechanisms.
In summary, we have developed a novel SLA-RT-PCR assay to efficiently and
accurately detect the distribution and relative quantity of the endogenously or
exogenously expressed miRNAs in mammalian cells by determining the authentic 3’end
and 5’ ends of mature miRNAs processed from their pre-miRNA sequences. We also
used the SLA-RT-PCR to accurately detect the specific sites and intermediate nucleic
acid fragments of DNA and mRNA targets cleaved by the restriction endonucleases in
solution and by the siRNA-Ago2 activity in the RISC in human cells, respectively. Our
results demonstrated the great potential and broad applications of using the SLA-RT-PCR
as a sensitive, cost-efficient, and high-throughput tool to systematically determine the
biogenesis and expression of endogenous miRNAs and to identify authentic miRNA
targets and determine mechanisms of siRNA and miRNA action by precisely detecting
and verifying the cleavage sites on target mRNAs mediated by siRNA or miRNAs in the
Ago2-RISCs in mammalian cells under physiological conditions.
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Chapter 4. Target mRNA cleavage and degradation mediated by endogenous
mammalian miRNAs
4.1 Introduction
Small RNA Lin-4 was first reported miRNA as gene regulatory molecule in 1993 [112]
and miRNA was later identified as a large class of short, single stranded RNAs presented
naturally in most eukaryotic cells [113,114,115]. Mature miRNAs are incorporated into
argonaute proteins as guide sequence in the assembling of miRNA-induced silencing
complex (miRISC) for target-specific gene silencing [116]. Plant miRNAs match their
mRNA target complementarily to ensure irreversible cleavage of target mRNAs and this
is thought to be the predominant mode of miRNA mechanism in plants [117]. In
mammalian cells, extended miRNA: target pairing are rare and miRNA recognizes
mRNA targets with much shorter base pairs usually located at highly conserved
nucleotides (nt) at position 2 -7 of miRNA 5’ termini with compensatory support from 3’
supplementary pairing [118]. The algorithm of mammalian miRNA: target recognition
makes it possible that a single miRNA might target hundreds of potential mRNA
transcripts genome-wide. Over the past few years, remarkable progress has been made in
our understanding of miRNA biogenesis and function; however, the mechanism that
miRNA use to regulate gene expression remains unclear. Earlier studies suggest that the
miRNA-induced gene expression interference is through binding to the 3’UTR of target
mRNA and repressing translation. Recent studies suggest that the mammalian miRNAs
predominantly act to decrease target mRNA levels. However, no direct evidence for
miRNA-mediated target mRNA cleavage and degradation has been demonstrated in
mammalian cells [119-121].
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Previous studies indicated that miRNA participate in the regulation of many crucial
cellular process. It was also predicted that mammalian miRNAs can regulate ~30% of all
protein coding genes by bioinformatics groups. The mechanism for miRNAs in
repressing protein synthesis is still poorly understood. miRNAs can affect both the
translation and stability of mRNAs, but the results from different studies have often been
contradictory. The recent development of ribosome profiling has provided a sensitive
method to verify that regulation by miRNA is mainly through mRNA destabilization.
In plants, miRNA pair to mRNAs with nearly perfect complementarity and trigger
endonucleolytic mRNA cleavage. In mammalians, there are rare examples of near-perfect
complementarity between miRNA and target site that enables cleavage of the mRNA,
such as in the case of miR-196 and HoxB8 mRNA [124]. Most cases, however, involve
duplexes that contain mismatches and multiple nucleotide bulges. Therefore, it is difficult
to predict and validate the target cleavage sites. In human somatic cells, argonaute protein
superfamily is composed of endonucleolytic-capable Ago2 protein and non-catalytic
Ago1, Ago3 and Ago4 proteins [122]. Ago2 is the only Ago that functions in the RNAi
because the RNase H-like-P-element induced PIWI domain, but not other Agos, can
cleave mRNA at the center of the siRNA-mRNA duplex. Ago2 is the only AGO that
partially because of the difference of catalytic capability of Ago2 and the noncatalytic
nature of other argonaute proteins, translational suppression and mRNA degradation were
both proposed as possible mechanisms in mammalian cells [123].
Later, a limited number of mRNA cleavages were mapped to near perfectly matched
miRNA:target with deep sequencing approaches. Owing to the limited cases of cleavages
observed and prerequisite of extensive base pairing between miRNA:target, miRNA59

mediated mRNA cleavages were regarded to be exceptional rather than a general rule for
mammalian gene silencing machinery [125,126,127]. We felt the detection methods used
in those studies, i.e., 5’-RACE, PARE, Ribosome profiling, lacked the necessary
sensitivity to address the short lived nature of mRNA intermediates in detail especially
when there were only small portion of mRNA cleavages overlapped among those reports.
With improved detecting methods, those few cases of miRNA cleavages could just be the
tip of iceberg.
miRNA-target interactions also stimulate miRNA degradation. It has been reported
that pairing between miRNA and targets can induce 3’end degradation of the miRNA,
which is followed by the addition of non-template uridines [104]. Uridine addition at the
3’end of miRNAs leads to miRNA destabilization.
One of the many challenges for studying mechanism of target regulation by miRNA is
the limited availability of miRNA-target interaction that has been validated in the
endogenous context. Often, target predictions are validated by fusing sequence that
contain the target sites to a reporter gene and assaying for regulation in the presence or
absence of the cognate miRNA. Here, the natural regulatory context is lost, both at the
level of the target sequence within its mRNA as well as at the level of cellular context.
However, it is possible now to identify endogenous miRNA-directed cleavage sites
through SLA-RT-PCR. Here, we used this method to examine whether Hmga2 mRNA
was a natural target of let-7 [128]. Hmga2 is a very good system to study endogenous
miRNA regulation mechanism, which has one perfect seed region base pairing in 5’ UTR
and seven perfect seed region base pairings to seed region of let-7 in 3’UTR, predicted by
bioinformatics computer program (Figure 25A and 25B). Additionally, we set out to
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discover the mechanism by which the target RNA is recognized and cleaved by
endogenous miRNA in physiological context. In the endogenous context, many factors
influence the ability of the miRNA targeting at mRNA targets.
A

B

Figure 25. Bioinformatic prediction of let-7 targets in Hmga2 mRNA. (A) Schematic
representation of Hmga2 gene targets by let-7 miRNA. (B) Sequence alignment of let-7a
complementary sites in the 5’UTR and 3’UTR of Hmga2 gene. Seed region (nucleotides
2 to 7) is highlighted in red.

61

With the limited miRNA seed region, other factors must influence target site selection
in the context. i.e. the position and context feature that contribute to target site selection
and efficiency. AU rich region enhance accessibility to the miRNA complex. In addition,
target sites tend to avoid sequence immediately after translation stop codon.
Hmga2 codes for a chromatin-associated protein, which has no intrinsic transcription
activity but can regulate transcription by altering the chromatin architecture [129].
Hmga2 is normally expressed at low levels in adult tissues; however, over-expression of
Hmga2 has been detected high expression in human tumors [130]. Let-7 family, one of
the well-studied of the miRNA families, was first identified in C. elegans [131]. It was
reported that let-7 acts as a tumor suppressor gene. Bartel et al. reported that the loss of
let-7 was associated with oncogenic Hmga2 translocations in various human tumors
[128].

4.2 Methods and Materials
4.2.1 SLA-RT-PCR for detection cleavage RNA fragments
Total RNA was prepared by using TRIzol reagent (Invitrogen, Carlbad, CA) and
phenol:chloroform according to standard total RNA isolation protocols. RNA was treated
with DNaseI to eliminate DNA contamination. RNA was reversed transcribed using the
High Capacity Reverse Transcription kit (Applied Biosystem) in combination with a
series of stem-loop RT-primers. Briefly, 10 µL RNA (50 ng) was supplemented with 2
µL RT primer (10 µM), 2 µL RT buffer (10 ×), 1 µL multiscribe reverse transcriptase,
0.8 µL dNTP mix (100 mM) in a total reaction volume of 20 µL. To increase reverse
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transcription efficiency, a pulsed RT reaction was performed (60 cycles of 18 °C for 1
min and 37 °C for 1 second, followed by 60 cycles of 20 °C for 1min and 37 °C for 1
second, and then 37 °C 30min, 42 °C 20 min, 85 °C 10min).
For each cDNA sample, RT product was diluted 500 fold. PCR reactions were
conducted as follows: 95 °C for 5 min followed by 35 cycles of 95 °C for 15 s, 61 °C for
30s, and 37 °C for 30s, then chased for 95°C for 15 s, 58 °C for 2 min, and 37 °C for 2
min.

4.2.2 Western blotting analysis
Proteins were resolved with 7.5% or 15% SDS-polyacrylamide gels and transferred to
Immobilon-P transfer membrane (Millipore). Primary antibodies used were rabbit antiAgo2 (Cell-Signaling), rabbit anti-GW182 (Novus), mouse anti-Hmga2 (Cell-Signaling),
rabbit TUTase-2 (Abnova), goat TUTase-3 (Abcam), and mouse anti-β-actin (Clontech).

4.2.3 Let-7 target plasmid construction
Dual let-7 target sequences were cloned into the 3’ UTR of the GFP gene in the vector
pLJT214. The first let-7 targets and the second let-7 target sequence were cloned directly
into the unique NheI-EcoRI and the unique BglII-xhoI restriction sites of the vector,
respectively
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4.3 Results
4.3.1 Let-7 mediated Hmga2 mRNA cleavage by the influence of Hmga2 mRNA
context
Total RNA from H1299 cells was chosen for this analysis. A collection of SL RT
primers with 6 nt probe matching along Hmga2 let-7 target sequence were designed to
detect the accumulation of cleaved mRNA fragments around 8 let-7 target sites. PCR
amplicons were analyzed on agarose electrophoresis gels in the order of let-7 miRNA
target sequence at 3’ - 5’ direction. Amplicon intensity of each PCR reaction represented
the relative abundance of 5’ fragment detected by a SL-RT primer respectively. We
detected these 8 predicted let-7 target sites have different cleavage efficiency, indicating
the other characteristics except 7 nt seed match help specify targeting. Importantly, the
context feature of target sites within an mRNA has been associated with how well it is
recognized and regulated by the miRISC, which may help explain the variable efficiency
in let-7 cleavage Hmga2 target mRNA.
The predicted 1# target site in 3’UTR, which is in the 15nt from stop codon, could no
longer cleaved by let-7 (Figure 27). It reaches the same conclusion that targets sites tend
to avoid sequence immediately after the translational stop codon, which is bound by the
ribosome. It suggested that miRISC might utilize the translation machinery to scan
mRNAs, as miRISC was found to be associated with ribosomal factors and was displaced
by the ribosome when the stop codon approached the ribosome A site. In addition, the
predicted -1# target site in 5’UTR can be cleaved by let-7 with the reduced efficacy
(Figure 26). The majority of miRNA target sites are reported in the 3’UTR of mRNAs,
which are more effective than those in either 5’ UTRs or ORF. The reduced efficacy of
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miRNA target sites in 5’UTR or ORF may be attributed to displacement of the miRISC
by ribosomes in 5’UTR and ORF, as miRISC passes from the cap to the start codon and
finally to stop codon by translocating ribosomes.
We detected the accumulation of let-7 cleaved 5’ fragments around target sites -1# 7# (Figure 26-33). SLA-RT-PCR revealed similar pattern around miRNA target sites,
which have elevated bands at central bulge, 3’ complimentary pairing region, 3’ adjacent
and 5’ adjacent region. Seed region is the only region without cleaved 5’ RNA fragment
accumulation. However, the target mRNA cleavage mechanisms in these regions are
different. Ago2 retains the ability to catalyze site-specific miRNA directed
endonucleolytic target cleavage, which requires the Watson–Crick pairing between
miRNA and target. The accumulation on 3’ adjacent region is because the let-7 target
sites block 3’-5’ degradation, and the increased band on 5’ adjacent region is due to the
3’-5’ degradation caused from the 3’ complimentary pairing region.
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SLA-RT primers list and detected corresponding RNA fragment
5’-

UGAGGUAGUAGGUUGUAUAGUU -3’
|||||||:|:| |
||
3’–CUCCACCUCCAUCGUUCUCCUCCUCCCUUCGCU5’
||||||
Stem loop RT probe (5’–3’)
C1
U2
C3
C4
A5
C6
C7
U8
C9
C10
A11
U12
C13
G14
U15
U16
C17
U18
C19
C20
U21
C22
C23
U24
C25
C26
C27
U28

SL- GAGGTG

HMGA2 Target

RNA Fragment Detected(3’–5’)
CUCCACCUCCAUCGUUCUCCUCCUCCCUUCGC

SL- AGGTGG

UCCACCUCCAUCGUUCUCCUCCUCCCUUCGC

SL- GGTGGA

CCACCUCCAUCGUUCUCCUCCUCCCUUCGC

SL- GTGGAG

CACCUCCAUCGUUCUCCUCCUCCCUUCGC

SL- TGGAGG

ACCUCCAUCGUUCUCCUCCUCCCUUCGC

SL- GGAGGT

CCUCCAUCGUUCUCCUCCUCCCUUCGC

SL- GAGGTA

CUCCAUCGUUCUCCUCCUCCCUUCGC

SL- AGGTAG

UCCAUCGUUCUCCUCCUCCCUUCGC

SL- GGTAGC

CCAUCGUUCUCCUCCUCCCUUCGC

SL- GTAGCA

CAUCGUUCUCCUCCUCCCUUCGC

SL- TAGCAA

AUCGUUCUCCUCCUCCCUUCGC

SL- AGCAAG

UCGUUCUCCUCCUCCCUUCGC

SL- GCAAGA

CGUUCUCCUCCUCCCUUCGC

SL- CAAGAG

GUUCUCCUCCUCCCUUCGC

SL- AAGAGG

UUCUCCUCCUCCCUUCGC

SL- AGAGGA

UCUCCUCCUCCCUUCGC

SL- GAGGAG

CUCCUCCUCCCUUCGC

SL- AGGAGG

UCCUCCUCCCUUCGC

SL- GGAGGA

CCUCCUCCCUUCGC

SL- GAGGAG

CUCCUCCCUUCGC

SL- AGGAGG
SL- GGAGGG
SL- GAGGGA
SL- AGGGAA
SL- GGGAAG
SL- GGAAGC
SL- GAAGCG
SL- AAGCGA

UCCUCCCUUCGC
CCUCCCUUCGC
CUCCCUUCGC
UCCCUUCGC
CCCUUCGC
CCUUCGC
CUUCGC
UUCGC

Figure 26. Detection of let-7 miRNA directed Hmga2 cleavage at target site 1# in 5’
UTR by SLA-RT-PCR. All PCR products were run in agarose gels and mapped to the
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position expected to let-7-directed Hmga2 cleavage. The expected PCR size was marked
with arrow at the left side of agarose gel. miRNA and target site seed region was
highlighted with red. Each SLA-RT primer and corresponding RNA cleaved fragment
which could be detected was illustrated in the table.

SLA-RT primers list and detected corresponding RNA fragment
5’-

UGAGGUAGUAGGUUGUAUAGUU -3’
||||||||::|:| |:|||
3’–ACGACGACUCCAUCUUUAGCUUGCAACCGCGG5’
||||||
Stem loop RT probe (5’–3’)
A1
C2
G3
A4
C5
G6
A7
C8
U9
C10
C11
A12
U13
C14
U15
U16
U17
A18
G19
C20
U21
U22
G23
C24
A25
A26
C27

SL- TGCTGC

HMGA2 Target

RNA Fragment Detected(3’–5’)
ACGACGACUCCAUCUUUAGCUUGCAACCGCGG

SL- GCTGCT

CGACGACUCCAUCUUUAGCUUGCAACCGCGG

SL- CTGCTG

GACGACUCCAUCUUUAGCUUGCAACCGCGG

SL- TGCTGA

ACGACUCCAUCUUUAGCUUGCAACCGCGG

SL- GCTGAG

CGACUCCAUCUUUAGCUUGCAACCGCGG

SL- CTGAGG

GACUCCAUCUUUAGCUUGCAACCGCGG

SL- TGAGGT

ACUCCAUCUUUAGCUUGCAACCGCGG

SL- GAGGTA

CUCCAUCUUUAGCUUGCAACCGCGG

SL- AGGTAG

UCCAUCUUUAGCUUGCAACCGCGG

SL- GGTAGA

CCAUCUUUAGCUUGCAACCGCGG

SL- GTAGAA

CAUCUUUAGCUUGCAACCGCGG

SL- TAGAAA

AUCUUUAGCUUGCAACCGCGG

SL- AGAAAT

UCUUUAGCUUGCAACCGCGG

SL- GAAATC

CUUUAGCUUGCAACCGCGG

SL- AAATCG

UUUAGCUUGCAACCGCGG

SL- AATCGA

UUAGCUUGCAACCGCGG

SL- ATCGAA

UAGCUUGCAACCGCGG

SL- TCGAAC

AGCUUGCAACCGCGG

SL- CGAACG

GCUUGCAACCGCGG

SL- GAACGT

CUUGCAACCGCGG

SL- AACGTT

UUGCAACCGCGG

SL- ACGTTG

UGCAACCGCGG

SL- CGTTGG

GCAACCGCGG

SL- GTTGGC
SL- TTGGCG
SL- TTGGCG
SL- TGGCGC
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CAACCGCGG
AACCGCGG
ACCGCGG
CCGCGG

SL- GGCGCC

C28

CGCGG

Figure 27. Detection of let-7 miRNA directed Hmga2 cleavage at target site 1# in 3’
UTR by SLA-RT-PCR. All PCR products were run in agarose gels and mapped to the
position expected to let-7-directed Hmga2 cleavage. The expected PCR size was marked
with arrow at the left side of agarose gel. miRNA and target site seed region was
highlighted with red. Each SLA-RT primer and corresponding RNA cleaved fragment
which could be detected was illustrated in the table.

SLA-RT primers list and detected corresponding RNA fragment
5’-

UGAGGUAGUAGGUUGUAUAGUU -3’
||||||: ||| | :|| |
3’–AAUUAAACUCCAUUCACCAUAAGUCCAGAAAGU5’
||||||
Stem loop RT probe (5’–3’)
A1
A2
U3
U4
A5
A6
A7
C8
U9
C10
C11
A12
U13
U14
C15
A16
C17
C18
A19
U20

SL-TTAATT

HMGA2 Target

RNA Fragment Detected(3’–5’)
AAUUAAACUCCAUUCACCAUAAGUCCAGAAAG

SL-TAATTT

AUUAAACUCCAUUCACCAUAAGUCCAGAAAG

SL-AATTTG

UUAAACUCCAUUCACCAUAAGUCCAGAAAG

SL-ATTTGA

UAAACUCCAUUCACCAUAAGUCCAGAAAG

SL-TTTGAG

AAACUCCAUUCACCAUAAGUCCAGAAAG

SL-TTGAGG

AACUCCAUUCACCAUAAGUCCAGAAAG

SL-TGAGGT

ACUCCAUUCACCAUAAGUCCAGAAAG

SL-GAGGTA

CUCCAUUCACCAUAAGUCCAGAAAG

SL-AGGTAA

UCCAUUCACCAUAAGUCCAGAAAG

SL-GGTAAG

CCAUUCACCAUAAGUCCAGAAAG

SL-GTAAGT

CAUUCACCAUAAGUCCAGAAAG

SL-TAAGTG

AUUCACCAUAAGUCCAGAAAG

SL-AAGTGG

UUCACCAUAAGUCCAGAAAG

SL-AGTGGT

UCACCAUAAGUCCAGAAAG

SL-GTGGTA

CACCAUAAGUCCAGAAAG

SL-TGGTAT

ACCAUAAGUCCAGAAAG

SL-GGTATT

CCAUAAGUCCAGAAAG

SL-GTATTC

CAUAAGUCCAGAAAG

SL-TATTCA

AUAAGUCCAGAAAG

SL-ATTCAG

UAAGUCCAGAAAG
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SL-TTCAGG

A21

AAGUCCAGAAAG

SL-TCAGGT

A22

AGUCCAGAAAG

SL-CAGGTC

G23

GUCCAGAAAG

SL-AGGTCT
SL-GGTCTT

U24
C25

UCCAGAAAG
CCAGAAAG

SL-GTCTTT

C26

CAGAAAG

SL-TCTTTC

A27

AGAAAG

SL-CTTTCA

G28

GAAAG

Figure 28. Detection of let-7 miRNA directed Hmga2 cleavage at target site 2# in 3’
UTR by SLA-RT-PCR. All PCR products were run in agarose gels and mapped to the
position expected to let-7-directed Hmga2 cleavage. The expected PCR size was marked
with arrow at the left side of agarose gel. miRNA and target site seed region was
highlighted with red. Each SLA-RT primer and corresponding RNA cleaved fragment
which could be detected was illustrated in the table.

SLA-RT primers list and detected corresponding RNA fragment
5’-

UGAGGUAGUA--GG-UUGU----AUAGUU3’
||||||||| |: | ||
||| |
3’–GUAAGUUCUCCAUCAUAACUCAUCACCCCUAUAUA-5’
||||||
Stem loop RT probe (5’–3’)
G1
U2
A3
A4
G5
U6
U7
C8
U9
C10
C11
A12

SL-CATTCA

HMGA2 Target

RNA Fragment Detected(3’–5’)
GUAAGUUCUCCAUCAUAACUCAUCACCCCUAUAUA

SL-ATTCAA

UAAGUUCUCCAUCAUAACUCAUCACCCCUAUAUA

SL-TTCAAG

AAGUUCUCCAUCAUAACUCAUCACCCCUAUAUA

SL-TCAAGA

AGUUCUCCAUCAUAACUCAUCACCCCUAUAUA

SL-CAAGAG

GUUCUCCAUCAUAACUCAUCACCCCUAUAUA

SL-AAGAGG

UUCUCCAUCAUAACUCAUCACCCCUAUAUA

SL-AGAGGT

UCUCCAUCAUAACUCAUCACCCCUAUAUA

SL-GAGGTA

CUCCAUCAUAACUCAUCACCCCUAUAUA

SL-AGGTAG

UCCAUCAUAACUCAUCACCCCUAUAUA

SL-GGTAGT

CCAUCAUAACUCAUCACCCCUAUAUA

SL-GTAGTA

CAUCAUAACUCAUCACCCCUAUAUA

SL-TAGTAT

AUCAUAACUCAUCACCCCUAUAUA
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U13
C14
A15
U16
A17
A18
C19
U20
C21
A22
U23
C24
A25
C26
C27
C28
C29
U30
A31
U32
A33
U34
A35

SL-AGTATT

UCAUAACUCAUCACCCCUAUAUA

SL-GTATTG

CAUAACUCAUCACCCCUAUAUA

SL-TATTGA

AUAACUCAUCACCCCUAUAUA

SL-ATTGAG

UAACUCAUCACCCCUAUAUA

SL-TTGAGT

AACUCAUCACCCCUAUAUA

SL-TGAGTA

ACUCAUCACCCCUAUAUA

SL-GAGTAG

CUCAUCACCCCUAUAUA

SL-AGTAGT

UCAUCACCCCUAUAUA

SL-GTAGTG

CAUCACCCCUAUAUA

SL-TAGTGG

AUCACCCCUAUAUA

SL-AGTGGG

UCACCCCUAUAUA

SL-GTGGGG
SL-TGGGGA

CACCCCUAUAUA
ACCCCUAUAUA

SL-GGGGAT

CCCCUAUAUA

SL-GGGATA

CCCUAUAUA

SL-GGATAT
SL-GATATA
SL-ATATAT
SL-TATATT
SL-ATATTG
SL-ATATTG
SL-TATTGC
SL-ATTGCA

CCUAUAUA
CUAUAUA
UAUAUA
AUAUA
UAUA
AUA
UA
A

Figure 29. Detection of let-7 miRNA directed Hmga2 cleavage at target site 3# in 3’
UTR by SLA-RT-PCR. All PCR products were run in agarose gels and mapped to the
position expected to let-7-directed Hmga2 cleavage. The expected PCR size was marked
with arrow at the left side of agarose gel. miRNA and target site seed region was
highlighted with red. Each SLA-RT primer and corresponding RNA cleaved fragment
which could be detected was illustrated in the table.
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SLA-RT primers list and detected corresponding RNA fragment
5’-

UGAGGUAGUAGGUUGUAUAGUU -3’
||||||
: ||| | ||
3’–AAGUAAACUCCAUGUCUGAACCUCCCAUU-5’
||||||
Stem loop RT probe (5’–3’)
A1
A2
G3
U4
A5
A6
A7
C8
U9
C10
C11
A12
U13
G14
U15
C16
U17
G18
A19
A20
C21
C22
U23
C24
C25
C26
A27
U28
U29

SL- TTCATT

HMGA2 Target

RNA Fragment Detected(3’–5’)
AAGUAAACUCCAUGUCUGAACCUCCCAUU

SL- TCATTT

AGUAAACUCCAUGUCUGAACCUCCCAUU

SL- CATTTG

GUAAACUCCAUGUCUGAACCUCCCAUU

SL- ATTTGA

UAAACUCCAUGUCUGAACCUCCCAUU

SL- TTTGAG

AAACUCCAUGUCUGAACCUCCCAUU

SL- TTGAGG

AACUCCAUGUCUGAACCUCCCAUU

SL- TGAGGT

ACUCCAUGUCUGAACCUCCCAUU

SL- GAGGTA

CUCCAUGUCUGAACCUCCCAUU

SL- AGGTAC

UCCAUGUCUGAACCUCCCAUU

SL- GGTACA

CCAUGUCUGAACCUCCCAUU

SL- GTACAG

CAUGUCUGAACCUCCCAUU

SL- TACAGA

AUGUCUGAACCUCCCAUU

SL- ACAGAC

UGUCUGAACCUCCCAUU

SL- CAGACT

GUCUGAACCUCCCAUU

SL- AGACTT

UCUGAACCUCCCAUU

SL- GACTTG

CUGAACCUCCCAUU

SL- ACTTGG

UGAACCUCCCAUU

SL- CTTGGA

GAACCUCCCAUU

SL- TTGGAG

AACCUCCCAUU

SL- TGGAGG

ACCUCCCAUU

SL- GGAGGG
SL- GAGGGT
SL- AGGGTA
SL- GGGTAA
SL- GGTAAT
SL- GTAATA
SL- TAATAT
SL- AATATT
SL- ATATTT
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CCUCCCAUU
CUCCCAUU
UCCCAUU
CCCAUU
CCAUU
CAUU
AUU
UU
U

Figure 30. Detection of let-7 miRNA directed Hmga2 cleavage at target site 4# in 3’
UTR by SLA-RT-PCR. All PCR products were run in agarose gels and mapped to the
position expected to let-7-directed Hmga2 cleavage. The expected PCR size was marked
with arrow at the left side of agarose gel. miRNA and target site seed region was
highlighted with red. Each SLA-RT primer and corresponding RNA cleaved fragment
which could be detected was illustrated in the table.

SLA-RT primers list and detected corresponding RNA fragment
5’-

UGAGGUAGUAGGUUGUAUAGUU -3’
|||||||
|||:||||:
3’–UCAGACCUCCAUCCAGAAACGUUCAGUU-5’
||||||
Stem loop RT probe (5’–3’)
U1
C2
A3
G4
A5
C6
C7
U8
C9
C10
A11
U12
C13
C14
A15
G16
A17
A18
A19
C20
G21
U22
U23

SL- AGTCTG

HMGA2 Target

RNA Fragment Detected(3’–5’)
UCAGACCUCCAUCCAGAAACGUUCAGUU

SL- GTCTGG

CAGACCUCCAUCCAGAAACGUUCAGUU

SL- TCTGGA

AGACCUCCAUCCAGAAACGUUCAGUU

SL- CTGGAG

GACCUCCAUCCAGAAACGUUCAGUU

SL- TGGAGG

ACCUCCAUCCAGAAACGUUCAGUU

SL- GGAGGT

CCUCCAUCCAGAAACGUUCAGUU

SL- GAGGTA

CUCCAUCCAGAAACGUUCAGUU

SL- AGGTAG

UCCAUCCAGAAACGUUCAGUU

SL- GGTAGG

CCAUCCAGAAACGUUCAGUU

SL- GTAGGT

CAUCCAGAAACGUUCAGUU

SL- TAGGTC

AUCCAGAAACGUUCAGUU

SL- AGGTCT

UCCAGAAACGUUCAGUU

SL- GGTCTT

CCAGAAACGUUCAGUU

SL- GTCTTT

CAGAAACGUUCAGUU

SL- TCTTTG

AGAAACGUUCAGUU

SL- CTTTGC

GAAACGUUCAGUU

SL- TTTGCA

AAACGUUCAGUU

SL- TTGCAA

AACGUUCAGUU

SL- TGCAAG

ACGUUCAGUU

SL- GCAAGT

CGUUCAGUU

SL- CAAGTC

GUUCAGUU

SL- AAGTCA

UUCAGUU

SL- AGTCAA
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UCAGUU

SL- GTCAAT

C24

CAGUU

SL- TCAATT

A25

AGUU

SL- CAATTA

G26

GUU

SL- AATTAG

U27

UU

SL- ATTAGT

U28

U

Figure 31. Detection of let-7 miRNA directed Hmga2 cleavage at target site 5# in 3’
UTR by SLA-RT-PCR. All PCR products were run in agarose gels and mapped to the
position expected to let-7-directed Hmga2 cleavage. The expected PCR size was marked
with arrow at the left side of agarose gel. miRNA and target site seed region was
highlighted with red. Each SLA-RT primer and corresponding RNA cleaved fragment
which could be detected was illustrated in the table.

SLA-RT primers list and detected corresponding RNA fragment
5’-

UGAGGUAGUAGGUUGUAUAGUU -3’
|||||||||:| |
||
3’–UGAAUUCUCCAUCAUCACACAAAACUAA-5’
||||||
Stem loop RT probe (5’–3’)
U1
G2
A3
A4
U5
U6
C7
U8
C9
C10
A11
U12
C13
A14
U15
C16

SL- ACTTAA

HMGA2 Target

RNA Fragment Detected(3’–5’)
UGAAUUCUCCAUCAUCACACAAAACUAA

SL- CTTAAG

GAAUUCUCCAUCAUCACACAAAACUAA

SL- TTAAGA

AAUUCUCCAUCAUCACACAAAACUAA

SL- TAAGAG

AUUCUCCAUCAUCACACAAAACUAA

SL- AAGAGG

UUCUCCAUCAUCACACAAAACUAA

SL- AGAGGT

UCUCCAUCAUCACACAAAACUAA

SL- GAGGTA

CUCCAUCAUCACACAAAACUAA

SL- AGGTAG

UCCAUCAUCACACAAAACUAA

SL- GGTAGT

CCAUCAUCACACAAAACUAA

SL- GTAGTA

CAUCAUCACACAAAACUAA

SL- TAGTAG

AUCAUCACACAAAACUAA

SL- AGTAGT

UCAUCACACAAAACUAA

SL- GTAGTG

CAUCACACAAAACUAA

SL- TAGTGT

AUCACACAAAACUAA

SL- AGTGTG

UCACACAAAACUAA

SL- GTGTGT

CACACAAAACUAA
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SL- TGTGTT

A17

ACACAAAACUAA

SL- GTGTTT

C18

CACAAAACUAA

SL- TGTTTT

A19

ACAAAACUAA

SL- GTTTTG

C20

CAAAACUAA

SL- TTTTGA

A21

AAAACUAA

SL- TTTGAT

A22

AAACUAA

SL- TTGATT

A23

AACUAA

SL- TGATTG

A24

ACUAA

SL- GATTGT

C25

CUAA

SL- ATTGTA

U26

UAA

SL- TTGTAC

A27

AA

SL- TGTACA

A28

A

Figure 32. Detection of let-7 miRNA directed Hmga2 cleavage at target site 6# in 3’
UTR by SLA-RT-PCR. All PCR products were run in agarose gels and mapped to the
position expected to let-7-directed Hmga2 cleavage. The expected PCR size was marked
with arrow at the left side of agarose gel. miRNA and target site seed region was
highlighted with red. Each SLA-RT primer and corresponding RNA cleaved fragment
which could be detected was illustrated in the table.

SLA-RT primers list and detected corresponding RNA fragment
5’-

UGAGGUAGUA--GGUUGUAUAGUU -3’
||||||||
||
||
3’–CUUUUUACUCCAUAUGACCCUGAAUUCUCCAUC-5’
||||||

RNA Fragment Detected(3’–5’)

Stem loop RT probe (5’–3’)
C1
U2
U3
U4
U5
U6
A7
C8
U9
C10
C11
A12

HMGA2 Target

SL- GAAAAA

CUUUUUACUCCAUAUGACCCUGAAUUCUCCAUC

SL- AAAAAT

UUUUUACUCCAUAUGACCCUGAAUUCUCCAUC

SL- AAAATG

UUUUACUCCAUAUGACCCUGAAUUCUCCAUC

SL- AAATGA

UUUACUCCAUAUGACCCUGAAUUCUCCAUC

SL- AATGAG

UUACUCCAUAUGACCCUGAAUUCUCCAUC

SL- ATGAGG

UACUCCAUAUGACCCUGAAUUCUCCAUC

SL- TGAGGT

ACUCCAUAUGACCCUGAAUUCUCCAUC

SL- GAGGTA

CUCCAUAUGACCCUGAAUUCUCCAUC

SL- AGGTAT

UCCAUAUGACCCUGAAUUCUCCAUC

SL- GGTATA

CCAUAUGACCCUGAAUUCUCCAUC

SL- GTATAC

CAUAUGACCCUGAAUUCUCCAUC

SL- TATACT

AUAUGACCCUGAAUUCUCCAUC
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U13
A14
U15
G16
A17
C18
C19
C20
U21
G22
A23
A24
U25
U26
C27
U28
C29
C30
A31
U32
C33

SL- ATACTG

UAUGACCCUGAAUUCUCCAUC

SL- TACTGG

AUGACCCUGAAUUCUCCAUC

SL- ACTGGG

UGACCCUGAAUUCUCCAUC

SL- CTGGGA

GACCCUGAAUUCUCCAUC

SL- TGGGAC

ACCCUGAAUUCUCCAUC

SL- GGGACT

CCCUGAAUUCUCCAUC

SL- GGACTT

CCUGAAUUCUCCAUC

SL- GACTTA

CUGAAUUCUCCAUC

SL- ACTTAA

UGAAUUCUCCAUC

SL- CTTAAG

GAAUUCUCCAUC

SL- TTAAGA

AAUUCUCCAUC

SL- TAAGAG

AUUCUCCAUC

SL- AAGAGG

UUCUCCAUC

SL- AGAGGT

UCUCCAUC

SL- GAGGTA

CUCCAUC

SL- AGGTAG
SL- GGTAGT
SL- GTAGTA
SL- TAGTAG
SL- AGTAGT
SL- GTAGTG

UCCAUC
CCAUC
CAUC
AUC
UC
C

Figure 33. Detection of let-7 miRNA directed Hmga2 cleavage at target site 7# in 3’
UTR by SLA-RT-PCR. All PCR products were run in agarose gels and mapped to the
position expected to let-7-directed Hmga2 cleavage. The expected PCR size was marked
with arrow at the left side of agarose gel. miRNA and target site seed region was
highlighted with red. Each SLA-RT primer and corresponding RNA cleaved fragment
which could be detected was illustrated in the table.

4.3.2 U-Tract added onto the exposed 3’ end of the cleaved 5’-fragment of Hmga2
target
RISC-generated products are eventually degraded by exoribonucleases: Xrn1, a 5’-3′
exonuclease, and exosome, a 3-5′multisubunit exonuclease. Interestingly, we recognized
an unexpected blank out in seed region, which do not have 3’-5’degradation. We then
asked if there is 3’ end modification at the end of seed region after cleavage by let-7,
which block 3’- 5’ degradation in the seed region. Nontemplated oligouridine were posttranscriptionally added to miRNA cleaved 5’ fragments as reported by Shen [132]. To
75

test if oligouridines were added to the 5’ fragments accumulated around let-7 target sites
on Hmga2 mRNA, we modified SL-RT primers with addition of a number of adenosines
at the 5’ end of primer probe to match possible nontemplated oligouridines at the 3’ end
of cleaved RNA fragments (Figure 34).

Figure 34. SLA-RT primers with addition of a number of adenosines at the 5’ end to
detect possible nontemplated oligouridines at the 3’ end of cleaved RNA fragments.

Total RNA from H1299 cells were tested with two sets of oligouridine detecting SL-RT
primers: SLA-RT primers and SLA-8U+RT primers (Figure 35-39). 8U-RT-PCR bands
increased in 3’ adjacent region, the end in seed region, and the 3’ complimentary pairing
region. These U sequences were not found in the genome, so they must have been added
after cleavage by let-7. The weak amplicon blocks in unmodified form in Figure 26-33
disappeared from oligouridylated groups (Figure 35-39). The drastically increased RNA
fragments in various length of oligouridylated form over unmodified form indicated that
oligouridine modification triggered accumulation rather than immediate degradation of
miRNA cleaved RNA fragments.
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SLA-RT primers and 8U-SLA-RT primers list

5’-

UGAGGUAGUAGGUUGUAUAGUU -3’
|||||||
|||:||||:
3’–UCAGACCUCCAUCCAGAAACGUUCAGUU-5’
||||||

HMGA2 Target

8U-Stem loop RT probe (5’–3’)

Regular Stem loop RT probe (5’–3’)
U1
C2
A3
G4
A5
C6
C7
U8
C9
C10
A11
U12
C13
C14
A15
G16
A17
A18
A19
C20
G21
U22
U23
C24
A25
G26
U27
U28

SL- AGTCTG

SL- AAAAAAAAGTCTG

SL- GTCTGG

SL- AAAAAAAAGTCTGG

SL- TCTGGA

SL- AAAAAAAATCTGGA

SL- CTGGAG

SL- AAAAAAAACTGGAG

SL- TGGAGG

SL- AAAAAAAATGGAGG

SL- GGAGGT

SL- AAAAAAAAGGAGGT

SL- GAGGTA

SL- AAAAAAAAGAGGTA

SL- AGGTAG

SL- AAAAAAAAAGGTAG

SL- GGTAGG

SL- AAAAAAAAGGTAGG

SL- GTAGGT

SL- AAAAAAAAGTAGGT

SL- TAGGTC

SL- AAAAAAAATAGGTC

SL- AGGTCT

SL- AAAAAAAAAGGTCT

SL- GGTCTT

SL- AAAAAAAAGGTCTT

SL- GTCTTT

SL- AAAAAAAAGTCTTT

SL- TCTTTG

SL- AAAAAAAATCTTTG

SL- CTTTGC

SL- AAAAAAAACTTTGC

SL- TTTGCA

SL- AAAAAAAATTTGCA

SL- TTGCAA

SL- AAAAAAAATTGCAA

SL- TGCAAG

SL- AAAAAAAATGCAAG

SL- GCAAGT

SL- AAAAAAAAGCAAGT

SL- CAAGTC

SL- AAAAAAAACAAGTC

SL- AAGTCA

SL- AAAAAAAAAAGTCA

SL- AGTCAA

SL- AAAAAAAAAGTCAA

SL- GTCAAT

SL- AAAAAAAAGTCAAT

SL- TCAATT

SL- AAAAAAAATCAATT

SL- CAATTA

SL- AAAAAAAACAATTA

SL- AATTAG

SL- AAAAAAAAAATTAG

SL- ATTAGT

SL- AAAAAAAAATTAGT
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Figure 35. let-7 miRNA directed uridylation of cleavage fragment at target site 5# in
3’UTR. All PCR products were run in agarose gels and mapped to the position expected
to let-7-directed Hmga2 cleavage. RNA was tested with two sets of SLA-RT primers:
SLA-RT primers and SLA-8U-RT primers, which listed in the table. 8U-RT-PCR bands
increased in 3’ adjacent region (highlighted with blue), the end in seed region
(highlighted with red), and the 3’ complimentary pairing region (highlighted with red).
The expected PCR size was marked with arrow at the left side of agarose gel. miRNA
and target site seed region was highlighted with red.

SLA-RT primers and 8U-SLA-RT primers list
5’-

UGAGGUAGUAGGUUGUAUAGUU -3’
|||||||:|:| |
||
3’–CUCCACCUCCAUCGUUCUCCUCCUCCCUUCGCU-5’
||||||

HMGA2 Target

8U-Stem loop RT probe (5’–3’)

Regular Stem loop RT probe (5’–3’)
C1
U2
C3
C4
A5
C6
C7
U8
C9
C10
A11
U12
C13
G14
U15
U16
C17
U18
C19
C20

SL- GAGGTG

SL-AAAAAAAAGAGGTG

SL- AGGTGG

SL-AAAAAAAAAGGTGG

SL- GGTGGA

SL-AAAAAAAAGGTGGA

SL- GTGGAG

SL-AAAAAAAAGTGGAG

SL- TGGAGG

SL-AAAAAAAATGGAGG

SL- GGAGGT

SL-AAAAAAAAGGAGGT

SL- GAGGTA

SL-AAAAAAAAGAGGTA

SL- AGGTAG

SL-AAAAAAAAAGGTAG

SL- GGTAGC

SL-AAAAAAAAGGTAGC

SL- GTAGCA

SL-AAAAAAAAGTAGCA

SL- TAGCAA

SL-AAAAAAAATAGCAA

SL- AGCAAG

SL-AAAAAAAAAGCAAG

SL- GCAAGA

SL-AAAAAAAAGCAAGA

SL- CAAGAG

SL-AAAAAAAACAAGAG

SL- AAGAGG

SL-AAAAAAAAAAGAGG

SL- AGAGGA

SL-AAAAAAAAAGAGGA

SL- GAGGAG

SL-AAAAAAAAGAGGAG

SL- AGGAGG

SL-AAAAAAAAAGGAGG

SL- GGAGGA

SL-AAAAAAAAGGAGGA

SL- GAGGAG

SL-AAAAAAAAGAGGAG
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SL- AGGAGG

U21

SL-AAAAAAAAAGGAGG

SL- GGAGGG

C22

SL-AAAAAAAAGGAGGG

SL- GAGGGA

C23

SL-AAAAAAAAGAGGGA

SL- AGGGAA

U24

SL-AAAAAAAAAGGGAA

SL- GGGAAG

C25

SL-AAAAAAAAGGGAAG

SL- GGAAGC

C26

SL-AAAAAAAAGGAAGC

SL- GAAGCG

C27

SL-AAAAAAAAGAAGCG

SL- AAGCGA

U28

SL-AAAAAAAAAAGCGA

Figure 36. let-7 miRNA directed uridylation of cleavage fragment at target site -1# in
5’UTR. All PCR products were run in agarose gels and mapped to the position expected
to let-7-directed Hmga2 cleavage. RNA was tested with two sets of SLA-RT primers:
SLA-RT primers and SLA-8U-RT primers, which listed in the table. 8U-RT-PCR bands
increased in 3’ adjacent region (highlighted with blue), the end in seed region
(highlighted with red), and the 3’ complimentary pairing region (highlighted with red).
The expected PCR size was marked with arrow at the left side of agarose gel. miRNA
and target site seed region was highlighted with red.

SLA-RT primers and 8U-SLA-RT primers list
5’-

UGAGGUAGUAGGUUGUAUAGUU -3’
||||||: ||| | :|| |
3’–AAUUAAACUCCAUUCACCAUAAGUCCA-5’
||||||

HMGA2 Target

8U-Stem loop RT probe (5’–3’)

Regular Stem loop RT probe (5’–3’)
A1
A2
U3
U4
A5
A6
A7

SL-TTAATT
SL-TAATTT

SL-AAAAAAAATTAATT
SL-AAAAAAAATAATTT

SL-AATTTG

SL-AAAAAAAAAATTTG

SL-ATTTGA

SL-AAAAAAAAATTTGA

SL-TTTGAG

SL-AAAAAAAATTTGAG

SL-TTGAGG

SL-AAAAAAAATTGAGG

SL-TGAGGT

SL-AAAAAAAATGAGGT
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C8
U9
C10
C11
A12
U13
U14
C15
A16
C17
C18
A19
U20
A21
A22
G23
U24
C25
C26
A27
G28

SL-GAGGTA

SL-AAAAAAAAGAGGTA

SL-AGGTAA

SL-AAAAAAAAAGGTAA

SL-GGTAAG

SL-AAAAAAAAGGTAAG

SL-GTAAGT

SL-AAAAAAAAGTAAGT

SL-TAAGTG

SL-AAAAAAAATAAGTG

SL-AAGTGG

SL-AAAAAAAAAAGTGG

SL-AGTGGT

SL-AAAAAAAAAGTGGT

SL-GTGGTA

SL-AAAAAAAAGTGGTA

SL-TGGTAT

SL-AAAAAAAATGGTAT

SL-GGTATT

SL-AAAAAAAAGGTATT

SL-GTATTC

SL-AAAAAAAAGTATTC

SL-TATTCA

SL-AAAAAAAATATTCA

SL-ATTCAG

SL-AAAAAAAAATTCAG

SL-TTCAGG

SL-AAAAAAAATTCAGG

SL-TCAGGT

SL-AAAAAAAATCAGGT

SL-CAGGTC

SL-AAAAAAAACAGGTC

SL-AGGTCT
SL-GGTCTT

SL-AAAAAAAAAGGTCT
SL-AAAAAAAAGGTCTT

SL-GTCTTT

SL-AAAAAAAAGTCTTT

SL-TCTTTC

SL-AAAAAAAATCTTTC

SL-CTTTCA

SL-AAAAAAAACTTTCA

Figure 37. let-7 miRNA directed uridylation of cleavage fragment at target site 2# in
3’UTR. All PCR products were run in agarose gels and mapped to the position expected
to let-7-directed Hmga2 cleavage. RNA was tested with two sets of SLA-RT primers:
SLA-RT primers and SLA-8U-RT primers, which listed in the table. 8U-RT-PCR bands
increased in 3’ adjacent region (highlighted with blue), the end in seed region
(highlighted with red), and the 3’ complimentary pairing region (highlighted with red).
The expected PCR size was marked with arrow at the left side of agarose gel. miRNA
and target site seed region was highlighted with red.
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SLA-RT primers and 8U-SLA-RT primers list
5’-

UGAGGUAGUA--GG-UUGU----AUAGUU3’
||||||||| |: | ||
||| |
3’–GUAAGUUCUCCAUCAUAACUCAUCACCCCUAUAUA-5’
||||||

HMGA2 Target

8U-Stem loop RT probe (5’–3’)

Regular Stem loop RT probe (5’–3’)
G1
U2
A3
A4
G5
U6
U7
C8
U9
C10
C11
A12
U13
C14
A15
U16
A17
A18
C19
U20
C21
A22
U23
C24
A25
C26
C27
C28
C29
U30
A31
U32
A33
U34
A35

SL-CATTCA

SL-AAAAAAAACATTCA

SL-ATTCAA

SL-AAAAAAAAATTCAA

SL-TTCAAG

SL-AAAAAAAATTCAAG

SL-TCAAGA

SL-AAAAAAAATCAAGA

SL-CAAGAG

SL-AAAAAAAACAAGAG

SL-AAGAGG

SL-AAAAAAAAAAGAGG

SL-AGAGGT

SL-AAAAAAAAAGAGGT

SL-GAGGTA

SL-AAAAAAAAGAGGTA

SL-AGGTAG

SL-AAAAAAAAAGGTAG

SL-GGTAGT

SL-AAAAAAAAGGTAGT

SL-GTAGTA

SL-AAAAAAAAGTAGTA

SL-TAGTAT

SL-AAAAAAAATAGTAT

SL-AGTATT

SL-AAAAAAAAAGTATT

SL-GTATTG

SL-AAAAAAAAGTATTG

SL-TATTGA

SL-AAAAAAAATATTGA

SL-ATTGAG

SL-AAAAAAAAATTGAG

SL-TTGAGT

SL-AAAAAAAATTGAGT

SL-TGAGTA

SL-AAAAAAAATGAGTA

SL-GAGTAG

SL-AAAAAAAAGAGTAG

SL-AGTAGT

SL-AAAAAAAAAGTAGT

SL-GTAGTG

SL-AAAAAAAAGTAGTG

SL-TAGTGG

SL-AAAAAAAATAGTGG

SL-AGTGGG

SL-AAAAAAAAAGTGGG

SL-GTGGGG
SL-TGGGGA

SL-AAAAAAAAGTGGGG
SL-AAAAAAAATGGGGA

SL-GGGGAT

SL-AAAAAAAAGGGGAT

SL-GGGATA

SL-AAAAAAAAGGGATA

SL-GGATAT

SL-AAAAAAAAGGATAT

SL-GATATA

SL-AAAAAAAAGATATA

SL-ATATAT

SL-AAAAAAAAATATAT

SL-TATATT

SL-AAAAAAAATATATT

SL-ATATTG

SL-AAAAAAAAATATTG

SL-ATATTG

SL-AAAAAAAAATATTG

SL-TATTGC

SL-AAAAAAAATATTGC

SL-ATTGCA

SL-AAAAAAAAATTGCA

Figure 38. let-7 miRNA directed uridylation of cleavage fragment at target site 3# in
3’UTR. All PCR products were run in agarose gels and mapped to the position expected
to let-7-directed Hmga2 cleavage. RNA was tested with two sets of SLA-RT primers:
SLA-RT primers and SLA-8U-RT primers, which listed in the table. 8U-RT-PCR bands
increased in 3’ adjacent region (highlighted with blue), the end in seed region
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(highlighted with red), and the 3’ complimentary pairing region (highlighted with red).
The expected PCR size was marked with arrow at the left side of agarose gel. miRNA
and target site seed region was highlighted with red.

SLA-RT primers and 8U-SLA-RT primers list
5’-

UGAGGUAGUAGGUUGUAUAGUU -3’
||||||
: ||| | ||
3’–AAGUAAACUCCAUGUCUGAACCUCCCAUU-5’
||||||

HMGA2 Target

8U-Stem loop RT probe (5’–3’)

Regular Stem loop RT probe (5’–3’)
A1
A2
G3
U4
A5
A6
A7
C8
U9
C10
C11
A12
U13
G14
U15
C16
U17
G18
A19
A20
C21

SL- TTCATT

SL- AAAAAAAATTCATT

SL- TCATTT

SL- AAAAAAAATCATTT

SL- CATTTG

SL- AAAAAAAACATTTG

SL- ATTTGA

SL- AAAAAAAAATTTGA

SL- TTTGAG

SL- AAAAAAAATTTGAG

SL- TTGAGG

SL- AAAAAAAATTGAGG

SL- TGAGGT

SL- AAAAAAAATGAGGT

SL- GAGGTA

SL- AAAAAAAAGAGGTA

SL- AGGTAC

SL- AAAAAAAAAGGTAC

SL- GGTACA

SL- AAAAAAAAGGTACA

SL- GTACAG

SL- AAAAAAAAGTACAG

SL- TACAGA

SL- AAAAAAAATACAGA

SL- ACAGAC

SL- AAAAAAAAACAGAC

SL- CAGACT

SL- AAAAAAAACAGACT

SL- AGACTT

SL- AAAAAAAAAGACTT

SL- GACTTG

SL- AAAAAAAAGACTTG

SL- ACTTGG

SL- AAAAAAAAACTTGG

SL- CTTGGA

SL- AAAAAAAACTTGGA

SL- TTGGAG

SL- AAAAAAAATTGGAG

SL- TGGAGG

SL- AAAAAAAATGGAGG

SL- GGAGGG

SL- AAAAAAAAGGAGGG
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C22
U23
C24
C25

SL- GAGGGT

SL- AAAAAAAAGAGGGT

SL- AGGGTA

SL- AAAAAAAAAGGGTA

SL- GGGTAA

SL- AAAAAAAAGGGTAA

SL- GGTAAT

C26
A27
U28
U29

SL- AAAAAAAAGGTAAT

SL- GTAATA

SL- AAAAAAAAGTAATA

SL- TAATAT

SL- AAAAAAAATAATAT

SL- AATATT

SL- AAAAAAAAAATATT

SL- ATATTT

SL- AAAAAAAAATATTT

Figure 39. let-7 miRNA directed uridylation of cleavage fragment at target site 4# in
3’UTR. All PCR products were run in agarose gels and mapped to the position expected
to let-7-directed Hmga2 cleavage. RNA was tested with two sets of SLA-RT primers:
SLA-RT primers and SLA-8U-RT primers, which listed in the table. 8U-RT-PCR bands
increased in 3’ adjacent region (highlighted with blue), the end in seed region
(highlighted with red), and the 3’ complimentary pairing region (highlighted with red).
The expected PCR size was marked with arrow at the left side of agarose gel. miRNA
and target site seed region was highlighted with red.

A terminal U tail on RNA is known to serve as a ‘‘mark’’ for 5’- 3’ degradation.
Certain types of mRNA, such as histone mRNA [133] and RNA interference cleavage
products [132] are uridylated before degradation. This oligo U tract is recognized by the
Lsm1–7 complex, which then appears to feed the transcript into the standard mRNA
decay pathways [134].
The next obvious question was which enzyme is responsible for uridylation after
cleaved by miRNAs. We examined whether terminal uridylyl transferase (TUTase) might
be responsible for the addition of an oligo U tail to RISC-generated RNA fragments.
Knocking down TUTase 3 erases the accumulation of U-tract added fragments to
background level. Knocking down TUTase 2 decreased uridylylized 5’ fragment only in
the seed region (Figure 40)
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SLA-RT primers and 8U-SLA-RT primers list
5’-

UGAGGUAGUAGGUUGUAUAGUU -3’
|||||||
|||:||||:
3’–UCAGACCUCCAUCCAGAAACGUUCAGUU-5’
||||||

HMGA2 Target

8U-Stem loop RT probe (5’–3’)

Regular Stem loop RT probe (5’–3’)
U1
C2
A3
G4
A5
C6
C7
U8
C9
C10
A11
U12
C13
C14
A15
G16
A17

SL- AGTCTG

SL- AAAAAAAAGTCTG

SL- GTCTGG

SL- AAAAAAAAGTCTGG

SL- TCTGGA

SL- AAAAAAAATCTGGA

SL- CTGGAG

SL- AAAAAAAACTGGAG

SL- TGGAGG

SL- AAAAAAAATGGAGG

SL- GGAGGT

SL- AAAAAAAAGGAGGT

SL- GAGGTA

SL- AAAAAAAAGAGGTA

SL- AGGTAG

SL- AAAAAAAAAGGTAG

SL- GGTAGG

SL- AAAAAAAAGGTAGG

SL- GTAGGT

SL- AAAAAAAAGTAGGT

SL- TAGGTC

SL- AAAAAAAATAGGTC

SL- AGGTCT

SL- AAAAAAAAAGGTCT

SL- GGTCTT

SL- AAAAAAAAGGTCTT

SL- GTCTTT

SL- AAAAAAAAGTCTTT

SL- TCTTTG

SL- AAAAAAAATCTTTG

SL- CTTTGC

SL- AAAAAAAACTTTGC

SL- TTTGCA

SL- AAAAAAAATTTGCA
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A18
A19
C20
G21
U22
U23
C24
A25
G26
U27
U28

C

SL- TTGCAA

SL- AAAAAAAATTGCAA

SL- TGCAAG

SL- AAAAAAAATGCAAG

SL- GCAAGT

SL- AAAAAAAAGCAAGT

SL- CAAGTC

SL- AAAAAAAACAAGTC

SL- AAGTCA

SL- AAAAAAAAAAGTCA

SL- AGTCAA

SL- AAAAAAAAAGTCAA

SL- GTCAAT

SL- AAAAAAAAGTCAAT

SL- TCAATT

SL- AAAAAAAATCAATT

SL- CAATTA

SL- AAAAAAAACAATTA

SL- AATTAG

SL- AAAAAAAAAATTAG

SL- ATTAGT

SL- AAAAAAAAATTAGT

D

Figure 40. Effects of 3’ terminal TUTases on the addition of uridine residues to the 3’ends of let-7 cleaved mRNA fragments. (A) Effects of uridylation of target site 5# after
treatment with TUTase2 siRNA and TUTase3 siRNA. The uridized sites at 3’ adjacent
region (highlighted with blue), the end in seed region (highlighted with red), and the 3’
complimentary pairing region (highlighted with red) 3’ adjacent region (highlighted with
blue), the end in seed region (highlighted with red), and the 3’ complimentary pairing
region (highlighted with red). Knocking down TUTase 3 erases the accumulation of Utract added fragments to background level. Knocking down TUTase 2 decreased
uridylylized 5’ fragment only in the seed region. The expected PCR size was marked
with arrow at the left side of agarose gel. miRNA and target site seed region was
highlighted with red. (B) The specific SL-RT primer and corresponding detected
cleavage RNA fragment was illustrated in the table. (C) Western blotting analysis and
(D) RT-PCR analysis of TUTase 2 and TUTase 3 after treatment with TUTase2 siRNA
and TUTase3 siRNA. TUTase2 siRNA inhibited TUTase2 expression, and TUTase3
siRNA inhibited TUTase3 expression.
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One possible explanation for observed miRNA cleavage pattern is that the retention of
miRISC on its miRNA sites hampers mRNA 3’-5’ degradation and the 3’-5’ partially
degraded mRNA fragments are further uridylylized by TUTase 3 recruited by miRISCs at
2 and 3 nt of 3’ adjacent region.

A

B
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C

SLA-RT primers and 8U-SLA-RT primers list
5’-

UGAGGUAGUAGGUUGUAUAGUU -3’
|||||||
|||:||||:
3’–UCAGACCUCCAUCCAGAAACGUUCAGUU-5’
||||||

HMGA2 Target

8U-Stem loop RT probe (5’–3’)

Regular Stem loop RT probe (5’–3’)
U1
C2
A3
G4
A5
C6
C7
U8
C9
C10
A11
U12
C13
C14
A15
G16
A17
A18
A19
C20
G21
U22
U23
C24
A25
G26
U27
U28

SL- AGTCTG

SL- AAAAAAAAGTCTG

SL- GTCTGG

SL- AAAAAAAAGTCTGG

SL- TCTGGA

SL- AAAAAAAATCTGGA

SL- CTGGAG

SL- AAAAAAAACTGGAG

SL- TGGAGG

SL- AAAAAAAATGGAGG

SL- GGAGGT

SL- AAAAAAAAGGAGGT

SL- GAGGTA

SL- AAAAAAAAGAGGTA

SL- AGGTAG

SL- AAAAAAAAAGGTAG

SL- GGTAGG

SL- AAAAAAAAGGTAGG

SL- GTAGGT

SL- AAAAAAAAGTAGGT

SL- TAGGTC

SL- AAAAAAAATAGGTC

SL- AGGTCT

SL- AAAAAAAAAGGTCT

SL- GGTCTT

SL- AAAAAAAAGGTCTT

SL- GTCTTT

SL- AAAAAAAAGTCTTT

SL- TCTTTG

SL- AAAAAAAATCTTTG

SL- CTTTGC

SL- AAAAAAAACTTTGC

SL- TTTGCA

SL- AAAAAAAATTTGCA

SL- TTGCAA

SL- AAAAAAAATTGCAA

SL- TGCAAG

SL- AAAAAAAATGCAAG

SL- GCAAGT

SL- AAAAAAAAGCAAGT

SL- CAAGTC

SL- AAAAAAAACAAGTC

SL- AAGTCA

SL- AAAAAAAAAAGTCA

SL- AGTCAA

SL- AAAAAAAAAGTCAA

SL- GTCAAT

SL- AAAAAAAAGTCAAT

SL- TCAATT

SL- AAAAAAAATCAATT

SL- CAATTA

SL- AAAAAAAACAATTA

SL- AATTAG

SL- AAAAAAAAAATTAG

SL- ATTAGT

SL- AAAAAAAAATTAGT

Figure 41. Let-7 sponge inhibited let-7 directed uridylation and cleavage activity of
Hmga2 mRNA. (A) let-7 sponge plasmid was constructed with GFP with two let-7 target
sites in 3’UTR. After transfection in H1299 cells, the GFP expression was dramatically
down-regulated compared with GFP expression plasmid, which indicated that the let-7
sponge exhausted let-7 miRNA in H1299 cells. H1299 cells were co-transfected with
RFP expression plasmid as transfection efficiency control. (B) After transfected with let7 sponge, the intensity of uridized PCR band was reduced compared to control group,
which indicated the let-7 directed uridized acitivity was inhibited by let-7 sponge. The
expected PCR size was marked with arrow at the left side of agarose gel. miRNA and
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target site seed region was highlighted with red. (C) The specific SL-RT primer and 8USL-RT primers were illustrated in the table.

Looking for Hmga2 is the true target of let-7; we conducted let-7 depletion by
transfected H1299 cells with let-7 sponge plasmid. When let-7 was depleted by let-7
sponge, the cleavage and uridylation activity on target site 5# was inhibited, suggesting
that the cleavage and uridylation activity is caused by let-7 (Figure 30).

4.3.3 Cooperativity between adjacent target sites, blocking 3’-5’ degradation caused
by the adjacent target sites
Based on our observations of le-7 targets on Hmga2, we hypothesized that when the
two miRNA sites were close together, miRNA will work cooperatively. Several earlier
studies have examined cooperative down-regulation via multiple miRNA target sites.
Grimson et al. observed that siRNA cooperatively silenced a reporter bearing two target
sites spaced 8-40 nt apart in 3’UTR. Expanding the distance to 56 nt disrupted the
cooperative function [135].
We noticed one notable exception: when target site 6# and target site 7# are too
close, in which the 5’ end of target site 7# is in the 3’ end of target site 6#, the cleavage
activity is dramatically reduced (Figure 32-33). One possible explanation is that if the
sites are too close there may be steric hindrance resulting in reduced function as we
observed with the 9 base spacing versus a single site.
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To characterize how different target RNA context influence RISC-mediated target
recognition and cleavage, we made plasmid PLJT214, which has two identical copies of
let-7 target sequence inserted at the 3’ UTR of GFP reporter plasmid, 262 bp apart
(Figure 42). Due to the identical target sequences were used in this plasmid constructs,
the different patterns and effectiveness of cleavage for the copies in tandem can only be
explained by the influence of mRNA context. The secondary structure was determined by
using the Mfold algorithm. Target site T1 cleavage and uridylation activity are much
efficient that target site T2, which may be explained by the position and secondary
structure of target site T1 is more optimistically for let-7 than target site T2.

Figure 42. Schematic representation of plasmid PLJT214 construction. Plasmid pLJT214
contain dual miR-98 target sequences added to the 3’ UTR of GFP transcript.
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A

B
5’- UGAGGUAGUAAGU---UGUAUUGUU -3’
|||||||:||:
|| | ||:|
3’–CUUAGCUCCAUCGUUUGCCGACUUUACGAG-5’
||||||

PLJT214 Target

8U-Stem loop RT probe (5’–3’)

Regular Stem loop RT probe (5’–3’)
C1
U2
U3
A4
G5
C6
U7
C8
C9
A10
U11
C12
G13
U14
U15
U16
G17
C18
C19

SL- GAATCG

SL- GAATCG

SL- AATCGA

SL- AATCGA

SL- ATCGAG

SL- ATCGAG

SL- TCGAGG

SL- TCGAGG

SL- CGAGGT

SL- CGAGGT

SL- GAGGTA

SL- GAGGTA

SL- AGGTAG

SL- AGGTAG

SL- GGTAGC

SL- GGTAGC

SL- GTAGCA

SL- GTAGCA

SL- TAGCAA

SL- TAGCAA

SL- AGCAAA

SL- AGCAAA

SL- GCAAAC

SL- GCAAAC

SL- CAAACG

SL- CAAACG

SL- AAACGG

SL- AAACGG

SL- AACGGC

SL- AACGGC

SL- ACGGCT

SL- ACGGCT

SL- CGGCTG

SL- CGGCTG

SL- GGCTGA

SL- GGCTGA

SL- GCTGAA

SL- GCTGAA
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G20
A21
C22
U23
U24
U25
A26
C27
G28
A29

SL- CTGAAA

SL- CTGAAA

SL- TGAAAT

SL- TGAAAT

SL- GAAATG

SL- GAAATG

SL- AAATGC

SL- AAATGC

SL- AATGCT

SL- AATGCT

SL- ATGCTC

SL- ATGCTC

SL- TGCTCT

SL- TGCTCT

SL- GCTCTA

SL- GCTCTA

SL- CTCTAC

SL- CTCTAC

SL- TCTACG

SL- TCTACG

Figure 43. Cooperativity between two adjacent target sites. (A) Plasmid PLJT214 was
cut by BglII to delete polyA tale, and cut by xhoI to delete target site T2. PLJT214,
PLJT214 cut by BglII, and PLJT214 cut by xhoI were transfected into H1299 cells
individually, and then SLA-RT-PCR detected the cleavage fragment and uridized
fragment. The expected PCR size for detecting target site 1# cleavage fragment was
labeled with T1, and for target site 2# was labeled with T2 with arrow at the left side of
agarose gel. miRNA and target site seed region was highlighted with red. After cutting by
xhoI, target site T2 cleavage and uridylation activity was totally gone, in addition, target
site T1 cleavage and uridylation activity was also dramatically reduced. (B) The specific
SL-RT primer and corresponding detected cleavage RNA fragment was illustrated in the
table.

Furthermore, PLJT214 was cut by BglII to delete polyA tale, and cut by xhoI to delete
target site T2. After cutting by xhoI, target site T2 cleavage and uridylation activity was
totally gone, in addition, target site T1 cleavage and uridylation activity was also
dramatically reduced (Figure 43). One possible explanation could be target site T1 and
target site T2 function cooperatively.
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4.4.4 Ago2 and GW182 are required for mediating miRNA targets cleavage and
degradation
The existence of a link between the miRNA pathway and mRNA decay is supported by
the observation that mammalian Agos, miRNAs and miRNA targets colocalize to
cytoplasmic foci know as P-bodies. Following this endonucleolytic cleavage by Ago2,
the resulting mRNA fragments are added oligo U by TUTase, which handed over to the
general 5’-3’ mRNA-decay machinery. Strikingly, all proteins that function in the 5'-3'
mRNA-decay pathway have now been shown to localize to P bodies.
GW182 have been shown to be associated with miRISC and required for miRNAmediated gene silencing. GW182 is localized to P bodies that are cytoplasmic messenger
ribonucleoprotein (mRNP) aggregates containing mRNA decay factors, translational
repressors and untranslated mRNAs. It is known that the oligo U tailored RNA fragments
can be recognized by GW182 and subject to further degradation in P body.
We further tested if depletion of Ago2 and GW182 impair miRNA directed target
cleavage and degradation. We knockdown Ago2 and GW182 in H1299 cells and carried
out SLA-RT-PCR on target site 5# (Figure 44A). Ago 2 and GW182 was efficiently
inhibited, which was confirmed by the western blotting (Figure 44B). When Ago2 and
GW182 were depleted, Hmga2 target site 5# cleavage and degradation products
decreased, which indicates that let-7 directed cleavage and uridylation activity are
dependent on Ago2 and GW182.
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A

B
5’-

UGAGGUAGUAGGUUGUAUAGUU -3’
|||||||
|||:||||:
3’–UCAGACCUCCAUCCAGAAACGUUCAGUU-5’
||||||

HMGA2 Target

8U-Stem loop RT probe (5’–3’)

Regular Stem loop RT probe (5’–3’)
U1
C2
A3
G4
A5
C6
C7
U8
C9
C10
A11
U12
C13
C14

SL- AGTCTG

SL- AAAAAAAAGTCTG

SL- GTCTGG

SL- AAAAAAAAGTCTGG

SL- TCTGGA

SL- AAAAAAAATCTGGA

SL- CTGGAG

SL- AAAAAAAACTGGAG

SL- TGGAGG

SL- AAAAAAAATGGAGG

SL- GGAGGT

SL- AAAAAAAAGGAGGT

SL- GAGGTA

SL- AAAAAAAAGAGGTA

SL- AGGTAG

SL- AAAAAAAAAGGTAG

SL- GGTAGG

SL- AAAAAAAAGGTAGG

SL- GTAGGT

SL- AAAAAAAAGTAGGT

SL- TAGGTC

SL- AAAAAAAATAGGTC

SL- AGGTCT

SL- AAAAAAAAAGGTCT

SL- GGTCTT

SL- AAAAAAAAGGTCTT

SL- GTCTTT

SL- AAAAAAAAGTCTTT
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A15
G16
A17
A18
A19
C20
G21
U22
U23
C24
A25
G26
U27
U28

SL- TCTTTG

SL- AAAAAAAATCTTTG

SL- CTTTGC

SL- AAAAAAAACTTTGC

SL- TTTGCA

SL- AAAAAAAATTTGCA

SL- TTGCAA

SL- AAAAAAAATTGCAA

SL- TGCAAG

SL- AAAAAAAATGCAAG

SL- GCAAGT

SL- AAAAAAAAGCAAGT

SL- CAAGTC

SL- AAAAAAAACAAGTC

SL- AAGTCA

SL- AAAAAAAAAAGTCA

SL- AGTCAA

SL- AAAAAAAAAGTCAA

SL- GTCAAT

SL- AAAAAAAAGTCAAT

SL- TCAATT

SL- AAAAAAAATCAATT

SL- CAATTA

SL- AAAAAAAACAATTA

SL- AATTAG

SL- AAAAAAAAAATTAG

SL- ATTAGT

SL- AAAAAAAAATTAGT

C

Figure 44. Knocking down Ago2 and GW182 inhibit Hmga2 cleavage and degradation
activity directed by let-7 miRNA. (A) Agarose gel electrophoresis of SLA-RT-PCR
products of target site 5# after Ago 2 and GW182 inhibition. The cleaved fragments
product (detected by SLA-RT) and uridized fragments product (detected by 8U-SLA-RT)
were inhibited after Ago2 inhibition and GW182 inhibition. The uridized region includes
3’ adjacent region (highlighted with blue), the end in seed region (highlighted with red),
and the 3’ complimentary pairing region (highlighted with red). The expected PCR size
was marked with arrow at the left side of agarose gel. miRNA and target site seed region
was highlighted with red. (B) The specific SLA-RT primer and corresponding detected
cleavage RNA fragment was illustrated in the table. (C) Western blotting analysis of
Ago2 and GW182 after H1299 treated with Ago2 siRNA and GW182 siRNA. Ago2
siRNA inhibited Ago2 expression, and GW182 siRNA inhibited GW182 expression.
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4.4.5 TUSC2 mRNA cleavage by miRNAs detected by SLA-RT-PCR
It has been confirmed that TUSC2 3’UTR played an important role in downregulating TUSC2 expression, which suggested miRNA may target on TUSC2 3’UTR.
Target Scan software (http://www.targetscan.org/) predicted TUSC2 mRNA have
hundreds of miRNA targets (Figure 45), which cannot be true and needs to be verified by
SLA-RT-PCR in physiological conditions. Random SL-RT primer was designed first for
screen the potential miRNA target on TUSC2, which has six random nucleotides at the
3’end of SLA-RT-primer (Figure 46).

Figure 45. miRNA targets on TUSC2 predicted by Target Scan Software
(http://www.targetscan.org/). It predicted TUSC2 mRNA have hundreds of miRNA
targets. miRNAs highlighted with purple predicted that target RNA have exact match to
positions 2-8 of the mature miRNA (the seed + position 8) followed by an 'A' . miRNAs
highlighted with red predicted that target RNA have an exact match to positions 2-8 of
the mature miRNA. miRNAs highlighted with blue predicted that target RNA have an
exact match to positions 2-7 of the mature miRNA (the seed) followed by an 'A'.
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Figure 46. SL-RT-PCR for screen miRNA targets cleavage fragments on TUSC2. SLRT-primer with six random nucleotides at 3’end was designed for screen cleavage
fragments.

B

A

C

Figure 47. Random SL-RT-PCR detected cleavage fragments on TUSC2. (A) Agarose
gel analysis of SL-RT-PCR product, the predicted miRNAs targets according to cleavage
fragments size and PCR primers were labeled. (B) DNA sequence verification of
cleavage fragments. The SL-RT primers were highlighted with blue. (C) Illustrations of
miRNAs targeted at TUSC2. The PCR primers and miRNAs are mapped at 3’UTR
according to the specific sizes.
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SL-RT-PCR with six random nucleotides at 3’end of SL-RT primer detected several
cleavage fragments. According to fragments size and predicted potential targets, miR-98,
miR-93, miR-637 and miR-23ab may direct TUSC2 cleavage. All cleavage fragments are
verified by DNA sequence (Figure 47).
It was reported that squamous metaplasia and dysplasia express significantly lower
levels of TUSC2 than normal and hyperplastic bronchial epithelia. SL-RT-PCR was used
to screen different miRNA targets among different lung cell lines. The results showed
that H1299 and H322 cells have miR-98 directed cleavage fragments, which cannot be
detected in A549 cells and HBE cells (Figure 48).

Figure 48. SL-RT-PCR detection of miRNAs directed mRNA cleavage fragments in
H1299, H322, A549 and HBEC cells. The predicted miRNAs targets according to
cleavage fragments size and PCR primers were labeled. H1299 and H322 cells have miR98 directed cleavage fragments, which cannot be detected in A549 cells and HBE cells.
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Previous report confirmed an authentic miR-98 target on TUSC2 mRNA 3’ UTR and
overexpressed miR-98 decreased TUSC2 mRNA level [86]. A collection of SLA-RT
primers with 6 nt probe matching along TUSC2 miR-98 target sequence were designed to
detect the accumulation of cleaved mRNA fragments around this site (Figure 49).
Amplicon intensity from each RT-PCR reaction represented the relative abundance of 5’
RNA fragment detected by a unique SL-RT primer respectively. PCR amplicons were
analyzed on agarose electrophoresis gels in the order of miR-98 target sequence at 3’-5’
direction. 5’ RNA fragment abundance around the endogenous TUSC2 miR-98 target
were represented as intensity of PCR amplicons ranging from 232 bp to 200 bp (Figure
49B). SLA-RT-PCR results showed the cleaved target sites are at C8, G31, A32, T33,
G34 around miR-98 target sites.
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A
TUSC2 mRNA
3’–UCCUUAGCUCCAUCGUUUGCCGACUUUACGAGACUGAUCCCCAAUUUUCCCUUCA-5’
||||||
Regular Stem loop RT probe (5’–3’)
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37

SL-AGGAAT
SL-AATCGA
SL-ATCGAG
SL-TCGAGG
SL-CGAGGT
SL-GAGGTA
SL-AGGTAG
SL-GGTAGC
SL-GTAGCA
SL-TAGCAA
SL-AGCAAA
SL-GCAAAC
SL-CAAACG
SL-AAACGG
SL-AACGGC
SL-ACGGCT
SL-CGGCTG
SL-GGCTGA
SL-GCTGAA
SL-CTGAAA
SL-TGAAAT
SL-GAAATG
SL-AAATGC
SL-AATGCT
SL-ATGCTC
SL-TGCTCT
SL-GCTCTG
SL-CTCTGA
SL-TCTGAC
SL-CTGACT
SL-TGACTA
SL-GACTAG
SL-ACTAGG
SL-CTAGGG
SL-GGGGTT
SL-GTTAAA
SL-AGGGAA
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B

C

Figure 49. SLA-RT-PCR detection of miR-98 directed TUSC2 cleavage fragments. (A)
SLA-RT primers design for detecting miR-98 directed cleavage fragments. (B) SLA-RTPCR products were run in agarose gels and mapped to the position expected to miR-98directed TUSC2 cleavage. The expected PCR size was marked with arrow at the left side
of agarose gel. Predicted target site region were highlighted with red. (C) DNA sequence
confirmation of miR-98 directed cleavage fragments. The SL-RT primers were
highlighted with red.
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A collection of SLA-RT primers were designed to detect the accumulation of cleaved
mRNA fragments around miR-637 target site (Figure 49A). SLA-RT-PCR results
showed the cleaved target sites are at C6, C10 and T13 around miR-637 target sites.
A
TUSC2 mRNA
3’–UUGACCCCCAAGCCCCCAACCCCCCGUUGUCAAUCAACGUCAUCCCCCUAGUC-5’
||||||
Regular Stem loop RT probe (5’–3’)
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27

SL-GGTTCG
SL-GTTCGG
SL-TTCGGG
SL-CGGGGT
SL-GGGTTG
SL-GGTTGG
SL-GTTGGG
SL-GGGGCA
SL-GGGCAA
SL-GGCAAC
SL-GCAACA
SL-CAACAG
SL-AACAGT
SL-ACAGTT
SL-CAGTTA
SL-AGTTAG
SL-GTTAGT
SL-TTAGTT
SL-TAGTTG
SL-AGTTGC
SL-GTTGCA
SL-TTGCAG
SL-TGCAGT
SL-GCAGTA
SL-CAGTAG
SL-AGTAGG
SL-GATCAG
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B

C

Figure 50. SLA-RT-PCR detection of miR-637 directed TUSC2 cleavage fragments.
(A) SLA-RT primers design for detecting miR-637 directed cleavage fragments. (B)
SLA-RT-PCR products were run in agarose gels and mapped to the position expected to
miR-637-directed TUSC2 cleavage. The expected PCR size was marked with arrow at
the left side of agarose gel. Predicted target site region were highlighted with red. (C)
DNA sequence confirmation of miR-637 directed cleavage fragments. The SL-RT
primers sequences were highlighted with red.
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To further confirm the effects of these miRNAs on TUSC2 protein expression, we cotransfected H1299 cells TUSC2-3’UTR construct and miR-93 inhibitor, miR-98 inhibitor,
miR-197 inhibitor, miR-637 inhibitor and miR-1207-5p inhibitor. As shown in Figure 51,
miR-98 inhibitor and miR-93 inhibitor increase the TUSC2 expression. In summary,
these results indicate that miR-93, miR-98, miR-637 down-regulate TUSC2 expression
through directed TUSC2 mRNA cleavage and degradation.

Figure 51. Expression of TUSC2 after treated with miRNA inhibitors. H1299 cell was
co-transfected with TUSC2 expression construct and miR-93 inhibitor, miR-98 inhibitor,
miR-197 inhibitor, miR-637 inhibitor, miR-1207-5p inhibitor. MiR-93 inhibitor and miR98 inhibitor increase TUSC2 expression.

4.5 Discussion
We have shown here that miRNA-directed endonucleolytic cleavage on mRNA was
the initiation step of miRNA mediated gene silence. The cleaved RNA fragments were
mostly oligouridylated at their 3’-termini and accumulated for RNA 5’ – 3’ decay later.
The portion of RNA fragments escaped oligouridine modification were subject to 3’ – 5’
decay pathway and would be intercepted by other miRISCs stationed on their target sites
at 5’ end. After shedding off exonucleases, RNA fragments were added with oligouridine
at their 3’ termini. In this process, miRISC performed two activities - endonucleolytic
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cleavage on mRNA targets and oligouridylation of cleaved 5’ RNA fragments.
Oligouridylation of RNA fragments played important role in stabilizing RNA for
accumulation and in converting RNA decay mode from 3’ - 5’ to 5’ - 3’. It would avoid
the problematic degradation of mRNA at 3’- 5’ direction which processed opposite the 5’
- 3’ flow of translation apparatus. In case of mRNA in active translation, RNA fragment
accumulation, other than degradation, gives time for translation to complete. This
eliminated the possible adverse consequences of truncated proteins which might be
produced with mRNA 3’ - 5’ decay pathway [127]. The delayed action on mRNA
degradation desynchronized the lineage relationship of mRNA and protein abundance
which contributed to the conflicted observation in many miRNA functionality tests [138,
139].
P-bodies are hubs for transient RNA species and played important role in miRNA
mediated gene silence. All the components for miRNA machinery, including Agos,
miRNA, GW182, Lsm1-7, XRN1, DCP1, CDP2, and Ccr4-Not complex can be found in
P-bodies [90]. Blocking miRNA silencing pathways at any step prevented P-body
formation, indicating that P bodies arise as a consequence of silencing [141-143]. The
miRNA cleaved fragments are accumulated in oligouridylated form which could be
recognized by cytoplasmic heptameric Lsm1-7 complex to facilitate the formation of Pbodies. The accumulated RNA fragments in P-bodies are eventually degraded through
RNA 5’ - 3’ decay pathway. Our results shed light on current knowledge of mature
mRNA degradation initiated by Ccr4-Not complex-deadenylation pathway which is, in
our opinion, too general to address tissue-specific mRNA half-lives. miRNA expression
profiling revealed that miRNAs were specific to tissue differentiation, physiological and
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pathogenic events [144, 145]. The micro-scale, leak-some and accumulative cleavage
activities of miRNA on target transcripts make them primary candidates for tissue and
event-specific mRNA half-life determinates in mammalian cells. The target site cleavage
efficiency by miRNA could be determined by target mRNA context which influence the
association and dissociation of the miRISC.
As currently available miRNA-target prediction algorithms do not take these issues
into account, it is conceivable that many proposed miRNA-target interactions occur only
in very specific contexts. Hence, the general applicability of proposed concepts of
miRNA functions that are based on the genome-wide prediction of seed-based miRNAtarget interactions need to be assessed cautiously. Without knowing these context
determinants, experimentalists face a difficult challenge. Where should they begin when
seeking to understand the molecular mechanisms of phenotypes arising from miRNA
knockdown or ectopic expression studies?
In this study, we tried to use the new developed SLA-RT-PCR method to identify the
miRNA target sites at TUSC2 3’TUR. It was reported by Lee et al. [146] that miR-378
could target TUSC2 3’UTR and repress the TUSC2 expression, leading to enhanced cell
survival, tumor growth, and angiogenesis in human NSCLC cells. Another group in UT
southwestern also reported that the 3’UTR of TUSC2 is a target of other miRNAs
including miR-93, miR-98, and miR-197 [136]. Down-regulation of TUSC2 expression
in both SCLC and NSCLC cell lines and primary tumors correlates with elevated miR-93
and miR-197 expression [136].
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The SLA-RT-PCR verified that miR-98, miR-93 and miR-637 directed TUSC2
cleaved and degraded. H1299 and H322 cells have miR-98 directed cleavage fragments,
which cannot be detected in A549 cells and HBE cells. The level of TUSC2 3’UTRmediated down-regulation of TUSC2 gene and protein expression is significantly higher
in lung cancer cells than in normal bronchial epithelial cells, which was might be
attributable to miR-98 targets in 3’UTR.
Our studies elucidated the mechanism that mammalian miRNA regulating target
mRNA degradation. These findings warrant further investigation to identify the precise
miRNA targets in mammalians in endogenous context. Our findings also demonstrated
that different miRNAs targeted at TUSC2 in different lung cell lines, which imply that
these miRNA can be used as potential therapeutic targets by effectively blocking the
interaction of miRNAs and TUSC2 targets to re-activate TUSC2 expression and restore
its tumor suppression function in tumor cells.
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